<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_PzYssEf">Mobile Apps and Quality of Life in Patients With Breast Cancer and Survivors: Systematic Literature Review</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Saeunn</forename><surname>Rut Saevarsdottir</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> University of Iceland , Department of Health Promotion , Sport &amp; Leisure Studies , Reykjavik , Iceland</note>
								<orgName type="department">Department of Health Promotion</orgName>
								<orgName type="institution" key="instit1">University of Iceland</orgName>
								<orgName type="institution" key="instit2">Sport &amp; Leisure Studies</orgName>
								<address>
									<settlement>Reykjavik</settlement>
									<country key="IS">Iceland</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>1</label> University of Iceland Department of Health Promotion , Sport &amp; Leisure Studies Stakkahlid Reykjavik , 105 Iceland</note>
								<orgName type="department">Department of Health Promotion</orgName>
								<orgName type="institution" key="instit1">University of Iceland</orgName>
								<orgName type="institution" key="instit2">Sport &amp; Leisure Studies Stakkahlid</orgName>
								<address>
									<postCode>105</postCode>
									<settlement>Reykjavik</settlement>
									<country key="IS">Iceland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mph</forename><forename type="middle">;</forename><surname>Sigridur</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Lara</forename><surname>Gudmundsdottir</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> University of Iceland , Department of Health Promotion , Sport &amp; Leisure Studies , Reykjavik , Iceland</note>
								<orgName type="department">Department of Health Promotion</orgName>
								<orgName type="institution" key="instit1">University of Iceland</orgName>
								<orgName type="institution" key="instit2">Sport &amp; Leisure Studies</orgName>
								<address>
									<settlement>Reykjavik</settlement>
									<country key="IS">Iceland</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Sidekick Health , Kopavogur , Iceland</note>
								<orgName type="institution">Sidekick Health</orgName>
								<address>
									<settlement>Kopavogur</settlement>
									<country key="IS">Iceland</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>1</label> University of Iceland Department of Health Promotion , Sport &amp; Leisure Studies Stakkahlid Reykjavik , 105 Iceland</note>
								<orgName type="department">Department of Health Promotion</orgName>
								<orgName type="institution" key="instit1">University of Iceland</orgName>
								<orgName type="institution" key="instit2">Sport &amp; Leisure Studies Stakkahlid</orgName>
								<address>
									<postCode>105</postCode>
									<settlement>Reykjavik</settlement>
									<country key="IS">Iceland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MPH</roleName><forename type="first">Saeunn</forename><forename type="middle">Rut</forename><surname>Saevarsdottir</surname></persName>
						</author>
						<title level="a" type="main" xml:id="_P6wFGA5">Mobile Apps and Quality of Life in Patients With Breast Cancer and Survivors: Systematic Literature Review</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">AC35D24DE0E251530D416B4383A65A38</idno>
					<idno type="DOI">10.2196/42852</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T08:13+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_H5dRCAd">mobile health</term>
					<term xml:id="_MHaT8w8">mHealth</term>
					<term xml:id="_kGuftjX">breast cancer</term>
					<term xml:id="_KkUrX3g">quality of life</term>
					<term xml:id="_ybv6s7D">review</term>
					<term xml:id="_PPGnmzr">systematic review</term>
					<term xml:id="_CUuwGMd">cancer treatment</term>
					<term xml:id="_F3gXh4p">mobile app</term>
					<term xml:id="_2s4Wgpa">patient care</term>
					<term xml:id="_uhSVAXU">survivorship</term>
					<term xml:id="_QXtJDXX">digital health intervention</term>
					<term xml:id="_TY4umpp">lifestyle intervention</term>
					<term xml:id="_8GGhnZ8">mobile phone Multidimensional Scale of Perceived Social Support Beck Depression Inventory Pain Impact Questionnaire-6. r RPM: remote patient monitoring. s FACT-ES: Functional Assessment of Cancer Therapy-Endocrine Symptoms BCPT: Breast Cancer Prevention Trial. x PROMIS: Patient-Reported Outcomes Measurement Information System</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_x5XcPe2"><p xml:id="_x42PKda"><s xml:id="_Mh2t6t2">Background: Side effects of breast cancer treatment may persist long into survivorship, reducing quality of life (QOL) in patients with breast cancer and survivors.</s><s xml:id="_hwXshGk">There is growing evidence for the use of digital health technologies, such as mobile apps, to support self-management, decrease symptom burden, and improve QOL in patients with cancer.</s><s xml:id="_7UqQent">However, an updated overview of the effects of mobile apps on QOL and well-being in patients with breast cancer and survivors is needed.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_CYzVgMc">Objective:</head><p xml:id="_Vmgvjmh"><s xml:id="_N4X7rdT">The aim of this review was to provide an overview of breast cancer-specific, mobile app-driven lifestyle or behavioral interventions in patient care through to survivorship and their impact on QOL and mental well-being.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_fMucKZN">Methods:</head><p xml:id="_KtFwEN4"><s xml:id="_qNT5pdS">A systematic search of PubMed, Scopus, and Web of Science was conducted to identify relevant studies.</s><s xml:id="_KKA6FEu">The inclusion criteria were limited to original studies involving a trial of a mobile app-driven lifestyle or behavioral intervention for patients with breast cancer or survivors and using QOL or well-being measures.</s><s xml:id="_Yf2SJ3H">The results of the studies that met the inclusion criterion were then synthesized in text and table format.</s><s xml:id="_k9HmPaz">The quality of the evidence was assessed with the Cochrane risk-of-bias tool.</s></p><p xml:id="_NVFsdSz"><s xml:id="_prjq46y">Results: A total of 17 studies with the number of participants ranging from 23 to 356 met the inclusion criterion.</s><s xml:id="_cUUrbmK">Of the 17 reviewed studies, 7 (41%) delivered an app-only intervention, and 10 (59%) combined an app with additional supporting materials, such as SMS text messaging, telecoaching, wearables, or printed materials.</s><s xml:id="_kcZ85ht">Among the 17 reviewed studies, 6 (35%) focused on aiding patients with breast cancer during the active treatment phase (excluding ongoing hormone therapy), whereas the remaining 11 (65%) focused on survivorship.</s><s xml:id="_kawvn85">The majority of the studies (14/17, 82%) observed some positive effects on QOL or well-being measures.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_zdHNjvE">Conclusions:</head><p xml:id="_7kEbZgg"><s xml:id="_Ymcy5rn">The results of the review indicate that mobile apps are a promising avenue for improving QOL and well-being in breast cancer care.</s><s xml:id="_Zt9VYet">Positive effects were observed in patients undergoing active treatment in all reviewed studies, but effects were less clear after chemotherapy and in long-term survivors.</s><s xml:id="_KRSyE9j">Although lifestyle and behavioral digital interventions are still being developed, and further research should still be pursued, the available data suggest that current mobile health apps aid patients with breast cancer and survivors.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="13" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="14" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="15" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="16" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="17" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="18" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="19" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_GvDhuny">Introduction</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_EsMfcTt">Background</head><p xml:id="_Wa6AZVF"><s xml:id="_2qd27mP">Breast cancer remains the leading cause of cancer-related deaths among women worldwide <ref type="bibr" target="#b0">[1]</ref>.</s><s xml:id="_WjgvWVW">Even so, thanks to improvements in early detection and breast cancer treatment, most Western countries have seen a reduction in mortality rates <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2]</ref>.</s><s xml:id="_XcHezxy">As a result, many breast cancer survivors live multiple productive years after treatment completion <ref type="bibr" target="#b2">[3]</ref>.</s><s xml:id="_U2A3BGY">However, the majority of cancer treatments severely affect quality of life (QOL), causing both physical and psychosocial side effects that may disrupt patients' physical function and mental well-being <ref type="bibr" target="#b3">[4]</ref>.</s><s xml:id="_asaZsw6">These side effects may persist and follow into survivorship.</s><s xml:id="_ppcdaFB">Physical symptoms, including chronic pain, paresthesia, allodynia, menopausal symptoms, weight problems, and fatigue, along with psychological distress, including the fear of recurrence, sleep disturbances, sexual issues, and cognitive problems, often persist <ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref>.</s><s xml:id="_JBxHmQ6">Furthermore, evidence suggests that breast cancer survivors are at an increased risk of adverse mental health outcomes such as anxiety and depression <ref type="bibr" target="#b7">[8]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_4WDGfVU">Various lifestyle and behavioral interventions have been shown</head><p xml:id="_HuR9EQd"><s xml:id="_JVgQuqZ">to improve the side effects experienced during and after breast cancer treatment as well as improve survival outcomes <ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref>. Regular physical activity (PA) after diagnosis has been found to be inversely associated with both breast cancer mortality and all-cause mortality, and even low-volume PA has been found to improve survival outcomes compared with inactivity <ref type="bibr" target="#b14">[15,</ref><ref type="bibr" target="#b15">16]</ref>.</s><s xml:id="_D2MEpaz">Furthermore, there is strong evidence supporting the positive effects of PA on cancer and treatment-related side effects <ref type="bibr" target="#b16">[17,</ref><ref type="bibr" target="#b17">18]</ref>.</s><s xml:id="_5bpyPcc">Integrative therapies, such as yoga and mindfulness, have been found to have a positive effect, particularly on the psychological health of patients with breast cancer and survivors, improving mental health, sleep disturbances, and perceived stress <ref type="bibr" target="#b11">[12,</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref>. Another important factor improving survival outcomes in patients with breast cancer is continued adherence to adjuvant endocrine therapy, yet nonadherence is common <ref type="bibr" target="#b22">[23,</ref><ref type="bibr" target="#b23">24]</ref>.</s><s xml:id="_8RZkcJU">Behavioral interventions using reminders and encouraging self-reporting medication adherence have been shown to increase adherence to adjuvant endocrine therapy, thus improving survival outcomes <ref type="bibr" target="#b24">[25]</ref>.</s><s xml:id="_abXWeWu">However, with the increasing numbers of cancer diagnoses and cancer survivors, the resource needs cannot always be met, in particular in patients progressing from their primary to follow-up treatments.</s><s xml:id="_UsaJNHE">Thus, the development and validation of easily accessible treatments have become a crucial need for this patient group.</s></p><p xml:id="_HsPxk6z"><s xml:id="_vE7puBc">There is a growing body of evidence supporting the use of digital health technologies in cancer care, helping patients to self-manage symptoms and side effects, improving QOL, and potentially increasing survival outcomes <ref type="bibr" target="#b25">[26,</ref><ref type="bibr" target="#b26">27]</ref>.</s><s xml:id="_JAC2c7C">Mobile health (mHealth), a subset of digital health, is defined as the use of mobile devices to support the delivery of health practices, often taking the form of a mobile app <ref type="bibr" target="#b27">[28]</ref>.</s><s xml:id="_hpbnaDZ">Compared with internet-based interventions, mobile apps are more user-friendly because they perform at a much faster speed than a website and may offer basic content and features even without an internet connection.</s><s xml:id="_d3WptMd">Providers of mHealth interventions can easily send push notifications to users, and interaction-enabled features and gestures (tapping, dragging, holding, and swiping) are much more elaborative in an mHealth intervention than in an intervention accessed via an internet site where design and features are constrained by web browsers.</s><s xml:id="_UvQKJzg">A limitation of mHealth is the low regulatory approval <ref type="bibr" target="#b28">[29]</ref>.</s><s xml:id="_QAB6JPN">Another subset of digital health, digital therapeutics (DTx), is however highly regulated, backed by clinical trials, and supported by real-world outcomes <ref type="bibr" target="#b29">[30]</ref>.</s><s xml:id="_APvD6VY">DTx apps deliver disease-specific interventions via high-quality software programs with the aim to treat, manage, or prevent disease through behavior changes <ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref>.</s><s xml:id="_WpE8pKW">With the majority of the world population being smartphone users, mHealth and DTx present a cost-effective solution to the growing need for accessible care <ref type="bibr" target="#b32">[33,</ref><ref type="bibr" target="#b33">34]</ref>, a solution considered by patients to be a useful complementary tool to usual care <ref type="bibr" target="#b34">[35]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Qnu3nXB">Objectives</head><p xml:id="_rvrTRSE"><s xml:id="_m9uujpW">Prior reviews support the use of mHealth interventions in general cancer care, suggesting that they may support self-management as well as decrease symptom burden, fatigue, and psychological distress <ref type="bibr" target="#b35">[36,</ref><ref type="bibr" target="#b36">37]</ref>.</s><s xml:id="_FZX9pqy">A recent meta-analysis concluded that the use of mHealth apps improves health-related QOL in patients with cancer, with the strongest evidence found for PA, cognitive behavioral therapy, and mindfulness <ref type="bibr" target="#b37">[38]</ref>.</s><s xml:id="_Dsw6qUt">However, the need for disease-focused solutions over generic ones has been emphasized <ref type="bibr" target="#b38">[39]</ref>.</s><s xml:id="_3MSfYjY">In a 2017 review focusing on QOL in patients with breast and prostate cancer, only 5 studies met the inclusion criteria.</s><s xml:id="_4aSWPkW">The authors concluded that the majority of these studies were of low-to-medium quality and that there was a lack of rigorous trials <ref type="bibr" target="#b39">[40]</ref>.</s><s xml:id="_rtS93DE">A 2019 review summarizing the effects of available apps on various outcomes in breast cancer found indications of their effectiveness in promoting weight loss, improving QOL, and decreasing stress <ref type="bibr" target="#b40">[41]</ref>.</s><s xml:id="_Rnpwhau">In a very recent publication, Patel et al <ref type="bibr" target="#b41">[42]</ref> point out that digital innovation in oncology lags behind other therapeutic areas despite there being a high unmet need among patients, health care providers, and caregivers.</s><s xml:id="_34qAweB">Importantly, there is a lack of data on the impact of digital treatments on QOL, which challenges optimal treatment decision-making.</s><s xml:id="_YKv9RjJ">Thus, with increasing numbers of breast cancer survivors, continual development and release of new breast cancer mHealth interventions, and the use of digital health apps being projected to rise rapidly, an updated synthesis of current research is timely.</s><s xml:id="_VsaDJxm">The aim of this review was to provide an overview of breast cancer-specific, mobile app-driven lifestyle or behavioral interventions in patient care through to survivorship and their impact on QOL and mental well-being.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_z4tBR8Y">Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_gVzdt4Q">Study Design</head><p xml:id="_57DJ2hp"><s xml:id="_eCX2sgd">A systematic review of the literature was performed following the PRISMA-checklist (see Multimedia Appendix 1).</s><s xml:id="_U8DT9Ac">The aim of a systematic review is to make available evidence more accessible by identifying, evaluating, and synthesizing the findings of relevant individual studies on a specific topic <ref type="bibr" target="#b42">[43]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Ma6QsJT">Search Strategy</head><p xml:id="_ZtG8hVk"><s xml:id="_7jxEX7U">An extended bibliography search was conducted on March 21, 2022, on PubMed, Scopus, and Web of Science.</s><s xml:id="_sQntPcJ">The search focused on mHealth in patients with breast cancer and survivors and the effect on QOL.</s><s xml:id="_UMrduAE">The following search query was used: (("digital therapeutics") OR ("digital health") OR (mhealth) OR ("mobile application") OR (app) OR (smartphone)) AND ((breast cancer) OR (breast neoplasm)) AND ((lifestyle) OR ("quality of life") OR (QOL) OR (anxiety) OR (depression) OR (mental health)).</s><s xml:id="_EQy6pJy">The search was limited to include results that contained the word "trial".</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_SCWS6aS">Selection of Studies</head><p xml:id="_FujT3Qf"><s xml:id="_3E9wXfD">No lower or upper published date limit was set on the search results.</s><s xml:id="_sQYsT6j">Only original research published in English was considered for inclusion.</s><s xml:id="_rZ8gddM">The inclusion criteria were further limited to research pertaining to mHealth, mobile apps, or DTx; breast cancer care or survivorship; and QOL or well-being.</s><s xml:id="_eYTnXSA">In this instance, lifestyle or behavioral interventions were defined as any intervention intended to modify or encourage certain behavior, such as exercise, nutrition, self-management, stress management, and medication adherence.</s><s xml:id="_d2YGWR8">Only studies using either direct QOL measurements or measurements related to mental well-being, such as anxiety or depression scales, were considered for inclusion.</s></p><p xml:id="_pDzT5pf"><s xml:id="_fnzsS84">Studies that did not include an intervention involving a mobile app and did not include patients with breast cancer or survivors as the study population were excluded.</s><s xml:id="_5WEk38q">Only studies directly related to breast cancer care or survivorship were considered for inclusion.</s><s xml:id="_zBruEJR">Studies involving mobile apps that were not directly applied to the study population (eg, health care professionals using mHealth apps to manage breast cancer care) were excluded, as were studies using an app without a lifestyle intervention (eg, symptom monitoring without self-management or lifestyle modification information).</s><s xml:id="_3uDnqJs">In addition, we excluded web-based interventions, telehealth interventions, and other digital health interventions that did not involve a mobile app.</s><s xml:id="_fdqsg6D">Furthermore, studies pertaining to app development were excluded.</s><s xml:id="_n5CVGXE">Only original research was included, and reviews, editorials, and protocols were excluded.</s><s xml:id="_b4GBpFA">Titles and abstracts were screened to identify appropriate articles.</s><s xml:id="_UwVgd4U">The initial screening and inclusion of articles was performed by SRS.</s><s xml:id="_rzePtKx">Both authors independently reviewed the remaining articles for the final selection.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_yCrMMJn">Data Extraction</head><p xml:id="_2kCW8ub"><s xml:id="_Gw2RXe9">Data were extracted and inputted into a Google Sheets file (Google LLC) by 1 reviewer (SRS) and then verified by a second reviewer (SLG).</s><s xml:id="_A6MJ6HQ">The following data were extracted for each included study: author and year of study; location of study, study population, and number of participants; brief description of the intervention delivered, intervention duration, and, when applicable, the follow-up period; control condition (if any); measurements; and key outcomes.</s><s xml:id="_NmbSHKc">Any discrepancies were resolved by discussion.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_NzSSesD">Quality Assessment of the Included Studies</head><p xml:id="_Zen84VX"><s xml:id="_yS9AvKk">The quality of each of the included studies was evaluated using the Cochrane Collaboration's 6-domain tool for assessing risk of bias in randomized trials.</s><s xml:id="_JSMNG8k">Study characteristics are classified as having high, low, or unclear risk of bias <ref type="bibr" target="#b43">[44]</ref>.</s><s xml:id="_D2Sqm7E">For each study, all items were first rated by 1 reviewer (SRS) and compiled in a Google Sheets file.</s><s xml:id="_h759RfN">Any doubts over unclear items were resolved by discussion between the authors.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_e4GUYzM">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_7JvmNKS">Study Selection</head><p xml:id="_BZMA4C5"><s xml:id="_f2QSvzt">A total of 346 articles were identified, of which, once duplicates were removed, 258 (74.6%) remained for primary analysis.</s><s xml:id="_yN7nKTw">Of these 258 articles, 55 (21.3%) were identified as involving a mobile app intervention with patients with breast cancer or survivors as the study population.</s></p><p xml:id="_zQJHkqJ"><s xml:id="_2hp5NBR">Subsequently, the full-text publications of these 55 articles were screened.</s><s xml:id="_Mj7Pzh3">In line with the defined exclusion criteria, the full-text screening excluded studies that were not breast cancer specific, involved commercially available health or wellness apps, were web based, had no quantitative measures, or had no QOL or well-being measures.</s><s xml:id="_tmbY58m">In addition, we excluded interventions that involved smartphones or tablet devices but did not include a specific mobile app <ref type="bibr" target="#b44">[45,</ref><ref type="bibr" target="#b45">46]</ref>.</s><s xml:id="_R8zCRkQ">Some of the studies (2/55, 4%) were excluded because they did not have a lifestyle or behavior modification element despite using an app <ref type="bibr" target="#b46">[47,</ref><ref type="bibr" target="#b47">48]</ref>.</s><s xml:id="_yyjpAY9">We also excluded studies where the feasibility of an app or the app functionality or engagement was being tested rather than the effectiveness of its contents on QOL and well-being <ref type="bibr" target="#b48">[49,</ref><ref type="bibr" target="#b49">50]</ref>.</s><s xml:id="_Prw6cSR">Furthermore, all secondary analyses were excluded, as were pilot or feasibility studies if subsequent randomized controlled trial (RCT) studies had been published.</s><s xml:id="_GaAHn6Z">Thus, of the initial 346 studies identified via database search, 17 (4.9%)</s><s xml:id="_yDRWtge">were included in the final review.</s><s xml:id="_mHJ8QJQ">The flow diagram in Figure <ref type="figure" target="#fig_0">1</ref> details the study screening and selection process.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_cJu5xHe">Study Characteristics</head><p xml:id="_G7zmF4q"><s xml:id="_kV9eBpM">The articles included were published between January 2017 and March 2022.</s><s xml:id="_PvSU8vM">Among the 17 articles, there were 10 (59%) RCTs, 5 (29%) pilot or feasibility studies, 1 (6%) nonrandomized controlled prospective cohort study, and 1 (6%) prospective quasi-randomized trial.</s><s xml:id="_YTVrhjV">All included articles studied an adult female population, either patients with breast cancer or survivors.</s><s xml:id="_VCdeSKF">The studies included were conducted in Asia (8/17, 47%), North America (5/17, 29%), and Europe (4/17, 24%).</s><s xml:id="_7CcZ7w4">The sample size ranged from 23 to 356 participants, with 24% (4/17) of the studies having a sample of &lt;50 participants, 35% (6/17) having a sample of between 50 and 100 participants, and 41% (7/17) having a sample of &gt;100 participants.</s><s xml:id="_symB5FV">The majority of the studies (14/17, 82%) had a control group receiving care as usual or an active control group receiving a separate intervention.</s></p><p xml:id="_UVY5Uej"><s xml:id="_AMrtxEa">Of the 17 reviewed studies, 7 (41%) delivered an app-only intervention, and 10 (59%) combined an app with additional supporting materials.</s><s xml:id="_nfmF7rR">The majority of the studies delivering a combined intervention used only 1 form of supporting material (7/10, 70%), whereas a minority used up to 3 forms of supporting materials (3/10, 30%).</s><s xml:id="_q7HzF7x">The supporting materials used included a combination of message-based reminders (SMS text message: 2/10, 20% and email: 1/10, 10%), wearables (pedometer: 1/10, 10% and Fitbit: 1/10, 10%), coaching calls (2/10, 20%), printed material (1/10, 10%), group support video calls (1/10, 10%), messaging group (1/10, 10%), other web-based material (2/10, 20%), and in-person rehabilitation sessions (1/10, 10%).</s></p><p xml:id="_JAGpKez"><s xml:id="_MYP66YH">The reviewed articles all delivered interventions that had the goal, either primary or secondary, of improving QOL or mental well-being in some way, consistent with the inclusion criteria.</s><s xml:id="_tD2snmb">The outcome measures varied across the studies, and the majority of the studies (15/17, 88%) measured more than 2 outcome variables.</s><s xml:id="_48ZtQ2c">The most common measurements (6/17, 35%) used for QOL were the European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire Core 30 (EORTC QLQ-C30) and the European Organization for Research and Treatment of Cancer Breast Cancer-Specific Quality-of-Life Questionnaire (EORTC QLQ-BR23).</s><s xml:id="_DsRrNtW">Many of the studies (4/17, 24%) also used the Functional Assessment of Cancer Therapy-Breast (FACT-B) or the Functional Assessment of Cancer Therapy-Endocrine Symptoms (FACT-ES).</s><s xml:id="_FBrJsWe">For anxiety or depressive symptoms, the most common scales used (4/17, 24%) were the Hospital Anxiety and Depression Scale (HADS) and the State-Trait Anxiety Inventory (STAI).</s><s xml:id="_m49Mj3B">However, other measurements were also used.</s><s xml:id="_774aMmd">The length of the interventions varied from 3 weeks to 12 weeks, with a minority of the studies including a follow-up period after intervention completion (4/17, 24%).</s></p><p xml:id="_VFaNPdJ"><s xml:id="_ueyMtHz">All reviewed studies included a sample of women with breast cancer or breast cancer survivors.</s><s xml:id="_cg9npDc">Of the 17 studies, 6 (35%) focused on aiding patients with breast cancer during the active treatment phase (excluding ongoing hormone therapy), whereas the remaining 11 (65%) focused on survivorship.</s><s xml:id="_KZ8F8Tp">Table <ref type="table" target="#tab_0">1</ref> summarizes the study characteristics, intervention design, and study results.</s><s xml:id="_2SrG7ds">Mobile apps during active treatment The intervention group showed a signif-Usual care Spielberger STAI c , RSES d , and an app satisfaction survey An mHealth b self-management psychoeducational app for breast cancer care, including information on breast Iran; 82 patients with nonmetastatic breast cancer; intervention group: 41 and control group: 41 RCT a Ghanbari et al [51], 2021 icant reduction in anxiety (P&lt;.001) compared with the control group and a significant increase in cancer and treatment, stress management techniques, self-esteem promotion, and self-esteem (P&lt;.001) anger management techcompared with the control group niques; patients in the intervention group could interact with each other and with a psychiatric nurse; intervention duration: 4 weeks; no follow-up The intervention group reported signifi-Usual care MSAS e and EORTC QLQ-C30 f A cancer care mHealth app called Interaktor intended for early identification and Sweden; 149 patients with breast cancer undergo-RCT Fjell et al [52], 2020 cantly lower prevalence of symptoms on management of symptoms ing neoadjuvant the QOL g scales: nau-as well as interaction with health care professionals; chemotherapy; intervention sea and vomiting the app included self-report-group: 74 and control group: 75 (P=.007),</s><s xml:id="_QBMguH7">appetite loss (P=.03), constipation ing of symptoms, as well as education and information (P=.007), and feeling regarding symptom selfsad, as well as signifimanagement; intervention cantly higher emotionduration: varied depending al functioning on length of chemotherapy; (P=.008) and lower measurements were taken at symptom distress (P=.004) baseline and 2 weeks after end of chemotherapy; no follow-up At 12 weeks, both groups showed im-Usual care EORTC QLQ-C30 and EORTC QLQ-BR23 h An mHealth app intended for breast cancer self-management support, which included education, exercise Taiwan; 112 newly diagnosed patients with breast cancer RCT Hou et al [53], 2020 provement in total QOL; the intervention and rehabilitation, diet and (stages 0-III); in-group had a higher nutrition, emotional support, tervention group: score in total QOL symptom and side effect 53 and control group: 59 and total breast cancer-specific QOL; (P=.04) no difference tracking, social resources, and experience sharing, as was found at the 6week measurement well as expert consulting; intervention duration: 12 weeks, measurements at 6 and 12 weeks; no follow-up XSL • FO RenderX Key outcomes Control condition Measurements Intervention description, duration, and follow-up (when applicable) Location, study population, and number of participants (n) Study design Study, year Global QOL (P=.02) and summary scores (P=.003) improved significantly in the intervention group compared with scores in the control group in the first week, and summary scores were still higher in the intervention group at the end of treatment (P=.002); no difference was observed in use of health care resources Usual care EORTC QLQ-C30, EORTC QLQ-BR23, and self-reported use of health care resources An mHealth app, mPro Mamma, that recorded symptoms and, depending on symptom severity, presented symptom self-management or advised seeking professional help, with symptom reports forwarded to an oncologist; intervention duration: varied depending on length of treatment, with measurements at 1 week after commencement of treatment and at completion of treatment; no followup Slovenia; 104 patients with nonmetastatic breast cancer undergoing chemotherapy; intervention group: 55 and control group: 49 Nonrandomized controlled prospective cohort study Grašič Kuhar et al [54], 2020 Decrease in self-efficacy (P=.03) and QOL (P=.03) after chemotherapy was significantly less in the intervention group; symptom interference was significantly less in the intervention group (P=.02); no significant difference in symptom severity; no difference observed for social support, anxiety, and depression; at 6month follow-up, no differences were found between the groups in any health outcomes Usual care SICPA i , MSPSS j , MD Anderson Symptom Inventory, FACT-B k , HADS l , and app use data, including log-in frequency and use time An mHealth breast cancer esupport app that included a learning forum, a discussion forum, an ask-the-expert forum, and a personal stories forum, as well as evidencebased information on breast cancer and symptom management; intervention duration: 12 weeks; 6-month follow-up China; 114 patients with breast cancer about to commence chemotherapy; intervention group: 57 and control group: 57 RCT Zhu et al [55], 2018 The intervention group showed increased QOL (P=.01), but no difference was found in depression or anxiety; in addition, the intervention group showed increased medication adherence compared with the control group (P&lt;.001) as well as lower rates in reported adverse events (P=.02)</s><s xml:id="_xeUZqWg">Usual care App satisfaction survey, use data, MARS m (Korean version), BDI n , Spielberger STAI, and WHOQOL-BREF o scale A mobile game with the intention to improve symptom self-management and reduce side effects of chemotherapy, with educational content on side effects and their prevention, as well as management of an avatar that was rewarded for performing activities such as exercise; intervention length: 3 weeks; no follow-up South Korea; 76 patients with metastatic breast cancer about to receive chemotherapy; intervention group: 36 and control group: 40 RCT Kim et al [56], 2018 Mobile apps for breast cancer survivors XSL • FO RenderX Key outcomes Control condition Measurements Intervention description, duration, and follow-up (when applicable) Location, study population, and number of participants (n) Study design Study, year No differences in QOL measurements or fatigue; the intervention group showed a significant improvement in VO 2peak and leg strength (P=.01), but no significant differences were found for other physical functions Control group was given a smartwatch to wear but did not receive access to the app Cardiorespiratory fitness (VO 2peak p ) measured by incremental multistage load on a bicycle ergometer, 6-minute walk test, 1-repetition maximum strength, chair-stand test, resting heart rate, blood pressure, body composition, Global Physical Activity Questionnaire score, Cancer Fatigue Scale-12, and health-related QOL; exercise adherence was measured via the app, and heart rate was measured using a smartwatch A home-based exercise program (habit-B), designed to incrementally increase level of strength, delivered via an mHealth app and a smartwatch, along with counseling or exercise guidance and support provided via email and the app; intervention duration: 12 weeks; no follow-up Japan; 50 breast cancer survivors (stages I-IIa) who had recently completed primary treatment; intervention group: 25 and control group: 25 RCT Ochi et al [57], 2022 The intervention group reported significantly fewer cases and lower severity of chronic pain (P=.02), as well as fewer cases of arm or hand swelling (P=.04), heaviness (P=.03), redness (P=.03), and limited mobility in the shoulder (P=.02) and arm (P=.03); number of lymphedema symptoms did not differ between the groups Control group: access to web and mobile limb mobility exercises, with a focus on precautionary lifestyle behaviors Lymphedema and Breast Cancer Symptom Experience Index (Part I), limb volume difference measured with an infrared Perometer, and PIQ-6 q , as well as height, body weight, BMI, and the Risk Reduction Behavior Checklist A web-and mobile-based intervention called The-Optimal-Lymph-Flow (TOLF); the web-based platform included information on lymphedema, self-care, and lymphatic exercises, as well as a section where patients could ask an expert questions, whereas the mHealth app offered an additional way of practicing the lymphatic exercises; intervention duration: 12 weeks; no follow-up United States; 120 breast cancer survivors who had undergone surgical treatment at least 3 months before enrollment, reported pain, and may or may not report lymphedema symptoms or have a history of lymphedema; intervention group: 60 and control group: 60 RCT Fu et al [58], 2022 The intervention group saw a positive impact on the majority of QOL measurements, including total (P=.003),</s><s xml:id="_rczmyAW">emotional (P=.007), and functional well-being (P=.01), as well as endocrine symptom s (P=.004); no difference between the groups for social or family well-being scores; distress scores in the intervention group were lower than those in the control group (P=.004)</s><s xml:id="_RvCsgA5">Usual care FACT-ES s qualityof-life scale, NCCN t Distress Thermometer, and an app satisfaction survey An mHealth app with educational content, relaxation exercises, guided imagery, symptom diary, and question module where patients could send questions to specialist nurses; the app included RPM r ; intervention duration: 12 weeks; no follow-up Turkey; 64 patients with breast cancer undergoing adjuvant endocrine hormone therapy; intervention group: 33 and control group: 31 RCT Çınar et al [59], 2021 Key outcomes Control condition Measurements Intervention description, duration, and follow-up (when applicable) Location, study population, and number of participants (n) Study design Study, year Both groups saw an improvement in QOL measures, but a more significant increase was seen in the intervention group (mHealth and rehabilitation); AROM and upper limb functionality were better in the intervention group (P&lt;.001); effects were maintained at 6-month follow-up (P&lt;.05), apart from those for emotional functioning, social functioning, systemic therapy side effects, and breast symptoms mHealth app and usual care Primary measurements were EORTC QLQ-C30 (version 3.0) and EORTC QLQ-BR23; secondary measurements were DASH u , AROM v of the shoulder using a goniometer, and upper body muscular strength using a digital handgrip; dualenergy x-ray absorptiometry was used to measure BMI, percentage fat mass, and bone mineral density An mHealth app, BENECA, as well as a 2-month in-person group rehabilitation program; the app allowed for energy feedback monitoring through user-recorded daily dietary and physical activity habits; the rehabilitation program focused on symptoms, therapeutic exercises, and psychomotricity; intervention duration: 8 weeks; follow-up at 6 months Spain; 80 breast cancer survivors (stages I-IIIA) who were overweight or obese at time of diagnosis; intervention group: 40 and control group: 40 RCT Lozano-Lozano et al [60], 2020 No difference was observed between the groups; improvements in breast cancer wellbeing were observed in both groups and maintained at the 2week follow-up (P=.02); breast cancer symptom burden declined at the end of the intervention in both groups (P=.03) but was not sustained at the 2-week followup An mHealth app, MyHealth, promoting healthy lifestyle behaviors; controls also received telecoaching BCPT w symptom checklist (25 items), FACT-B (36 items), as well as acceptability and feasibility An mHealth app, MyGuide, designed to reduce symptom burden and improve healthrelated QOL through coping strategies, ongoing medication adherence, cancer knowledge, optimizing social support, psychosocial adaptation, and stress management; participants also received telecoaching; intervention duration: 6 weeks; follow-up at 2 weeks United States; 80 Latinx breast cancer survivors (stages 0-III) within 2 to 24 months of completing primary treatment; intervention group: 40 and control group: 40 Pilot study Yanez et al [61], 2020 Fatigue (P=.02) and health distress (P=.01) levels were lower, self-reported knowledge of cancer care and resources increased (P=.03), and emotional well-being (P=.02) and daily steps (P=.02) increased; no change was found in the other secondary measurements or in self-efficacy N/A z Primary measurements: adapted version of the PROMIS x Cancer Fatigue Scale, adapted version of the MOS y Health Distress Scale, knowledge of cancer questionnaires, and an 8-item self-efficacy scale; secondary measurements: the 6-item Emotional Well-Being Scale from the Functional Assessment of Cancer Treatment-General, the Patient Health Questionnaire (8item version), and the 6-item Brief Symptom Inventory Somatization Scale A Spanish language mHealth app, trackC, with integrated activity tracker (Fitbit Zip), a hard copy survivor care planning program and information booklet, and health coaching telephone calls; the app provided information on potential side effects, healthy lifestyles, and survivorship resources; intervention duration: 2 months; no follow-up United States; 23 Spanish-speaking breast cancer survivors who completed primary treatment within 1 year Feasibility study Nápoles et al [62], 2019 Key outcomes Control condition Measurements Intervention description, duration, and follow-up (when applicable) Location, study population, and number of participants (n) Study design Study, year No changes were observed for depressive symptoms, fatigue, pain interference, and physical functioning; however, study power was insufficient for these end points; improvements were observed in mental health functioning (P=.007) and perceived stress (P=.04); self-reported medication adherence increased (P=.02); and decreases in estradiol, estrogen, and estrone hormone levels were observed from baseline (P&lt;.001; supporting the accuracy of the self-reported medication adherence scores); no other changes were observed; the majority of participants (P&lt;.001) and physicians (100%) reported satisfaction with the intervention N/A BCPT symptom checklist, Concerns About Recurrence Scale, 12-item Communication and Attitudinal Self-Efficacy-cancer scale, Center for Epidemiologic Studies Depression Scale, Brief Pain Inventory interference subscale, 7item Fatigue Symptom Inventory interference subscale, Short Form-8 Health Survey (version 2), 14-item Perceived Stress Scale, 5-item Social Desirability Response Set, 20item MOS Social Support Questionnaire, and medication adherence Daily medication reminders as well as weekly medication adherence reporting reminders via SMS text message; medication adherence was reported using an mHealth adherence app; intervention duration: 3 months; no follow-up United States; 39 postmenopausal breast cancer survivors (stages 0-III) who had completed primary treatment and were eligible for receiving adjuvant hormone therapy Pilot study Krok-Schoen et al [63], 2019 Improvements were observed for the index score (P=.02) and the visual analog scale score (P=.002) on the EQ-5D; spiritual wellbeing scores (Functional Assessment of Chronic Illness Therapy-Spiritual Well-being 12-item Scale) increased (P=.01); psychological subscale (P=.05) and physical and daily living subscales (P=.003) scores of the Supportive Care Needs Survey-Short Form 34 reduced; and overall fear of recurrence decreased (P=.01); no other measurements observed reached significance N/A Concerns About Recurrence Scale (Japanese version), HADS, EQ-5D, Functional Assessment of Chronic Illness Therapy-Spiritual Well-being 12item Scale, Supportive Care Needs Survey-Short Form 34, and Social Problem-Solving Inventory-Revised Short Form Problem-solving therapy delivered via an mHealth app aimed to reduce the fear of recurrence; intervention duration: 8 weeks; no follow-up Japan; 38 breast cancer survivors &gt;6 months after surgery Pilot study Imai et al [64], 2019 Saevarsdottir &amp; Gudmundsdottir JOURNAL OF MEDICAL INTERNET RESEARCH XSL • FO RenderX Key outcomes Control condition Measurements Intervention description, duration, and follow-up (when applicable) Location, study population, and number of participants (n) Study design Study, year QOL did not differ between groups and neither did cancer worry, distress, or empowerment; improvements in medication adherence were observed but not sustained at the 6-month follow-up; more peer support was reported in the peer-support meetings than in the online support group meetings; overall app satisfaction was low Usual care The Symptom Checklist-90, the Empowerment Questionnaire for patients with breast cancer, the 8-item Cancer Worry Scale, EORTC QLQ-C30 (version 3.0) and EORTC QLQ-BR23), and MARS; in addition, feasibility, acceptability, and practicability of myGMC were measured, along with self-reported use statistics Face-to-face group medical consultation as well as access to mHealth app (myGMC); each patient received an iPad with the myGMC app, video chat app FaceTalk, reading app (iBooks), and contact information app (Contacts); the myGMC app included 13 short videos of interviews with breast cancer survivors; the other apps were used for online support group sessions, survivorship information, and contact information for the other members of the support group (a clinical nurse and the researcher); intervention duration: 3 months; follow-up at 6 months The Netherlands; 122 survivors of nonmetastatic breast cancer who had completed primary treatment; intervention group: 63 and control group: 59 RCT Visser et al [65], 2018 Both groups showed an increase in symptom burden after initiation of aromatase inhibitors; although the increase was less in the intervention group, it did not reach statistical significance; the intervention group had a higher proportion of app log-ins and higher medication adherence than the control group' participants reported satisfaction with the app App only Morisky Medication Adherence Scale-4, FACT-ES, app use log, and user feedback An mHealth app along with weekly reminders via SMS text message, email, or both; the app encouraged tracking medication adherence and treatment-related symptoms; intervention duration: 8 weeks; no follow-up United States; 48 breast cancer survivors (stages 0-III) who had completed primary treatment and been prescribed aromatase inhibitors; intervention group: 23 and control group: 25 Randomized pilot study Graetz et al [66], 2018 Key outcomes Control condition Measurements Intervention description, duration, and follow-up (when applicable) Location, study population, and number of participants (n) Study design Study, year Physical functioning, QOL, and self-reported physical activity increased in both groups; the intervention group reported high satisfaction regarding the mHealth app Same 12-week regimen of aerobic and resistance exercise but in brochure form Various physical measurements, International Physical Activity Questionnaire-Short Form, EORTC QLQ-C30 and EORTC QLQ-BR23, and mHealth user satisfaction survey An mHealth app and pedometer with a 12-week regimen of aerobic and resistance exercise; intervention duration: 12 weeks; no follow-up South Korea; 356 breast cancer survivors who had completed primary treatment; intervention group: 179 and control group: 177 Prospective quasi-randomized trial</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_pMtv9Xm">Mobile Apps During Active Treatment</head><p xml:id="_Kmj5MV9"><s xml:id="_UEKtmmf">Symptom management was the primary focus for the majority of the articles identified (5/6, 83%) that delivered an intervention during active treatment <ref type="bibr" target="#b51">[52]</ref><ref type="bibr" target="#b52">[53]</ref><ref type="bibr" target="#b53">[54]</ref><ref type="bibr" target="#b54">[55]</ref><ref type="bibr" target="#b55">[56]</ref>.</s><s xml:id="_d9dSfUQ">However, many of the interventions (3/6, 50%) also connected patients with health care professionals <ref type="bibr" target="#b50">[51]</ref><ref type="bibr" target="#b51">[52]</ref><ref type="bibr" target="#b52">[53]</ref>, some (2/6, 33%) focused on mental health <ref type="bibr" target="#b50">[51,</ref><ref type="bibr" target="#b54">55]</ref>, some (3/6, 50%) focused on social support <ref type="bibr" target="#b50">[51,</ref><ref type="bibr" target="#b52">53,</ref><ref type="bibr" target="#b54">55]</ref>, and 1 (17%) of these 6 studies included a component on exercise and nutrition <ref type="bibr" target="#b52">[53]</ref>.</s><s xml:id="_F7BJcgR">All studies used an mHealth app, one of which was a mobile game-based app <ref type="bibr" target="#b55">[56]</ref>; however, none of the studies specified using a DTx app.</s><s xml:id="_fYM2bYN">All studies indicated some positive effects on QOL or well-being measurements <ref type="bibr" target="#b50">[51]</ref><ref type="bibr" target="#b51">[52]</ref><ref type="bibr" target="#b52">[53]</ref><ref type="bibr" target="#b53">[54]</ref><ref type="bibr" target="#b54">[55]</ref><ref type="bibr" target="#b55">[56]</ref>.</s></p><p xml:id="_hd4kVBg"><s xml:id="_2TSrNCe">Of the 6 studies, 4 (67%) specifically related to patients with breast cancer undergoing chemotherapy <ref type="bibr" target="#b51">[52,</ref><ref type="bibr" target="#b53">[54]</ref><ref type="bibr" target="#b54">[55]</ref><ref type="bibr" target="#b55">[56]</ref>.</s><s xml:id="_creFfAP">Fjell et al <ref type="bibr" target="#b51">[52]</ref> randomized 149 patients with breast cancer undergoing neoadjuvant chemotherapy to receive access to an mHealth app-Interaktor-or care as usual.</s><s xml:id="_XpXAfkw">Patients self-reported symptoms within the app, which offered education on symptom self-management and remote patient monitoring (RPM).</s><s xml:id="_A3RvJHJ">At the end of the intervention duration, which varied depending on each patient's chemotherapy schedule, the intervention group reported significantly lower prevalence of chemotherapy-related side effects, higher emotional functioning, and lower overall symptom distress as well as physical symptom distress <ref type="bibr" target="#b51">[52]</ref>.</s><s xml:id="_kMVxwRG">Zhu et al <ref type="bibr" target="#b54">[55]</ref> randomized 114 patients with breast cancer about to commence chemotherapy to receive a breast cancer e-support mHealth app or care as usual for 12 weeks.</s><s xml:id="_vbZQWWs">The app was intended for education, symptom management, and social support.</s><s xml:id="_5bDJat9">It included a learning forum, a discussion forum, a personal stories forum, and an ask-the-expert forum.</s><s xml:id="_f78cVRk">After commencement of chemotherapy, a decrease in QOL and self-efficacy was observed in both groups, but the decrease was significantly less in the intervention group, as was the decrease in symptom interference.</s><s xml:id="_wPS2FrP">No significant difference was observed for symptom severity, social support, anxiety, or depression.</s><s xml:id="_zeg3A7E">At the end of the 6-month follow-up, no significant differences were observed between the groups <ref type="bibr" target="#b54">[55]</ref>.</s><s xml:id="_DFGKpnU">Kim et al <ref type="bibr" target="#b55">[56]</ref> randomized 76 patients with metastatic breast cancer to receive access to a mobile game app or care as usual for 3 weeks.</s><s xml:id="_7pdTBvk">The mobile game was intended to improve self-management and reduce chemotherapy-related side effects.</s><s xml:id="_3NdtmB4">The game included educational content as well as the control of a personalized avatar.</s><s xml:id="_Q2TzrQV">There was an increase in medication adherence and QOL as well as lower rates in reported adverse events in the intervention group compared with the control group.</s><s xml:id="_4FHzaXK">No significant differences were observed for depression or anxiety.</s><s xml:id="_7QqkbUJ">However, more than half of the participants in the intervention group reported finding the game difficult to use <ref type="bibr" target="#b55">[56]</ref>.</s><s xml:id="_pRTkhfh">In their prospective controlled cohort study, Grašič Kuhar et al <ref type="bibr" target="#b53">[54]</ref> gave the intervention group (n=55) access to an mHealth app, mPro Mamma.</s><s xml:id="_4WdT6GT">The app allowed for recording of symptoms and severity and delivered symptom self-management techniques and RPM.</s><s xml:id="_KRvPrNR">The control group had undergone treatment in the year prior, when the app was not yet fully developed.</s><s xml:id="_bgM5g4a">At the end of treatment, the QOL summary scores were significantly higher in the intervention group than in the control group <ref type="bibr" target="#b53">[54]</ref>.</s></p><p xml:id="_YG8GErG"><s xml:id="_SXDc8Cg">Hou et al <ref type="bibr" target="#b52">[53]</ref> focused on newly diagnosed patients with breast cancer, randomizing 112 participants to receive a symptom self-management app or care as usual for 12 weeks.</s><s xml:id="_JdZkEqz">The app included educational content, exercises, dietary advice, symptom tracking, emotional support, and experience sharing, as well as expert consulting.</s><s xml:id="_9KeXgk4">Although both groups reported an increase in total QOL EORTC QLQ-C30), the increase was significantly more in the intervention group, as was the increase in functional scores <ref type="bibr" target="#b52">[53]</ref>.</s></p><p xml:id="_yagRVgQ"><s xml:id="_Q6pSjgg">One of the studies delivering mHealth alongside clinical care focused primarily on mental health.</s><s xml:id="_ZzRj9Q6">Ghanbari et al <ref type="bibr" target="#b50">[51]</ref> randomized 82 patients with breast cancer to receive either an intervention (a self-management psychoeducational app) or care as usual.</s><s xml:id="_AcEvVDP">The app included educational information as well as stress and anger management techniques, along with self-esteem promotion.</s><s xml:id="_WX73EDy">In addition, there was a social support group on the messaging app WhatsApp, where the patients in the intervention group could interact with each other as well as with a psychiatric nurse.</s><s xml:id="_kdudg9M">After the 4-week intervention, the intervention group showed a significant reduction in anxiety (state, trait, and total) as well as a significant increase in self-esteem when compared with the control group <ref type="bibr" target="#b50">[51]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_FKrnDVz">Mobile Apps in Survivorship</head><p xml:id="_nEePvnx"><s xml:id="_9kqPbaX">The intervention focus varied for the reviewed studies focusing on mobile apps in survivorship.</s><s xml:id="_HEfSBUw">More than one-third (4/11, 36%) of the studies either focused on, or included an element of, PA as part of the intervention <ref type="bibr" target="#b56">[57,</ref><ref type="bibr" target="#b59">60,</ref><ref type="bibr" target="#b61">62,</ref><ref type="bibr" target="#b66">67]</ref>.</s><s xml:id="_jpMDSEk">Some of the studies (3/11, 27%) included a focus on symptom burden <ref type="bibr" target="#b58">[59,</ref><ref type="bibr" target="#b60">61,</ref><ref type="bibr" target="#b61">62]</ref>, 9% (1/11) of the studies included RPM <ref type="bibr" target="#b58">[59]</ref>, 18% (2/11) addressed medication adherence <ref type="bibr" target="#b62">[63,</ref><ref type="bibr" target="#b65">66]</ref>, 9% (1/11) focused on lymphedema management <ref type="bibr" target="#b57">[58]</ref>, 9% (1/11) focused on social support <ref type="bibr" target="#b64">[65]</ref>, and 9% (1/11) specifically addressed the fear of recurrence <ref type="bibr" target="#b63">[64]</ref>.</s><s xml:id="_GparZXb">All studies used an mHealth app, most of them (9/11, 82%) in conjunction with supporting materials <ref type="bibr" target="#b56">[57,</ref><ref type="bibr" target="#b57">58,</ref><ref type="bibr" target="#b59">[60]</ref><ref type="bibr" target="#b60">[61]</ref><ref type="bibr" target="#b61">[62]</ref><ref type="bibr" target="#b62">[63]</ref><ref type="bibr" target="#b64">[65]</ref><ref type="bibr" target="#b65">[66]</ref><ref type="bibr" target="#b66">[67]</ref>; however, none of the studies specified using a DTx app.</s></p><p xml:id="_dh5b3qt"><s xml:id="_ewA77Hf">The studies that focused on PA had mixed results regarding QOL measurements.</s><s xml:id="_sYaFbkF">Ochi et al <ref type="bibr" target="#b56">[57]</ref> randomized 50 breast cancer survivors to receive an mHealth app and a smartwatch or a smartwatch alone for 12 weeks.</s><s xml:id="_FanPH3V">The app delivered a home-based exercise program, habit-B, with exercises designed to incrementally increase the patients' level of strength.</s><s xml:id="_qCSMksK">The intervention group showed significant improvements in some physical functions, including aerobic capacity (peak oxygen uptake) and leg strength, compared with the control group.</s><s xml:id="_ZaqafUU">However, no significant differences were observed for QOL measurements <ref type="bibr" target="#b56">[57]</ref>.</s><s xml:id="_KQRfkD7">In the RCT conducted by Lozano-Lozano et al <ref type="bibr" target="#b59">[60]</ref>, which involved 80 breast cancer survivors who were overweight or obese at diagnosis, both groups received access to an mHealth app, BENECA, but the intervention group also received an in-person rehabilitation program.</s><s xml:id="_Qh396fW">The app encouraged monitoring of daily dietary and PA habits to monitor energy feedback.</s><s xml:id="_pycTAnx">The rehabilitation program included group sessions that focused on symptoms, therapeutic exercises, and psychomotricity, which refers to movements intended to enhance potential development or recovery and encompasses aspects of self-awareness <ref type="bibr" target="#b67">[68,</ref><ref type="bibr" target="#b68">69]</ref>.</s><s xml:id="_xG7rbP8">At the end of the 8-week intervention, an improvement in QOL measures was found in both groups, but the increase was significantly greater in the intervention group, as was upper limb functionality and active range of motion of the shoulder <ref type="bibr" target="#b59">[60]</ref>.</s><s xml:id="_QGW47Fu">Uhm et al <ref type="bibr" target="#b66">[67]</ref> compared a 12-week exercise regimen delivered through an mHealth app along with a pedometer with the same program delivered in brochure form in a sample of 356 breast cancer survivors.</s><s xml:id="_EdznfCK">Both groups were found to have a significant increase in QOL, physical function, and self-reported PA.</s><s xml:id="_QsJUvEU">The difference between the groups was not significant <ref type="bibr" target="#b66">[67]</ref>.</s></p><p xml:id="_3ZWARed"><s xml:id="_tcG3C4j">Nápoles et al <ref type="bibr" target="#b61">[62]</ref> had a mixed focus on symptom burden, self-efficacy, and PA in their feasibility study.</s><s xml:id="_59sqFMm">In this small study, 23 Spanish-speaking breast cancer survivors received access to an mHealth app, trackC, with an integrated activity tracker, hard-copy informational material, and telecoaching.</s><s xml:id="_5CQMfA2">The app included individual treatment history as well as information on potential side effects, healthy lifestyles, and survivorship resources.</s><s xml:id="_gH3hQ72">The integrated activity tracker was intended to promote PA through daily step goals.</s><s xml:id="_8qtCSgT">At the end of the 2-month intervention, significant improvements were observed in fatigue, health distress, and emotional well-being compared with baseline.</s><s xml:id="_rQ7xphh">Daily steps and self-reported knowledge of cancer care and resources increased significantly.</s><s xml:id="_SttS8H7">However, no significant change was observed in self-efficacy <ref type="bibr" target="#b61">[62]</ref>.</s><s xml:id="_hkdaETJ">Another study focusing on Spanish-speaking breast cancer survivors also included a focus on symptom burden.</s><s xml:id="_QBp3Fyj">In their pilot study, Yanez et al <ref type="bibr" target="#b60">[61]</ref> randomized 80 Latina breast cancer survivors to receive 1 of 2 mHealth apps.</s><s xml:id="_ejmTZ7e">The intervention group received access to MyGuide, an mHealth app designed to reduce symptom burden and improve QOL through educational content, medication adherence, social support and psychosocial adaptation, stress management, and coping strategies.</s><s xml:id="_StswCuE">The control group received access to MyHealth, an mHealth app designed to promote healthy lifestyle behaviors such as nutrition and PA.</s><s xml:id="_Euze785">Both groups also received telecoaching.</s><s xml:id="_9t248Yq">At the end of the 6-week intervention, an improvement in symptom burden was observed in both groups; however, no significant differences were observed between the groups <ref type="bibr" target="#b60">[61]</ref>.</s></p><p xml:id="_ABS3CBj"><s xml:id="_ZhBxwyg">Krok-Schoen et al <ref type="bibr" target="#b62">[63]</ref> focused on increasing adherence to adjuvant hormone therapy.</s><s xml:id="_Mc5GtRQ">In this pilot study, 39 postmenopausal breast cancer survivors received daily SMS text message reminders as well as access to an mHealth app intended for self-reporting medication adherence.</s><s xml:id="_CzQ4py4">At the end of the 3-month intervention, self-reported medication adherence increased significantly from baseline, and blood tests confirmed lower hormone levels, suggesting accuracy in the self-report measurements.</s><s xml:id="_Dg6MnPR">Moreover, significant improvements were observed in mental health functioning and perceived stress <ref type="bibr" target="#b62">[63]</ref>.</s></p><p xml:id="_m6WsN4J"><s xml:id="_VES9vhm">In their pilot study, Graetz et al <ref type="bibr" target="#b65">[66]</ref> randomized 44 breast cancer survivors who had been prescribed aromatase inhibitors (AI) to have access to an app that encouraged tracking medication adherence and treatment-related symptoms.</s><s xml:id="_7HKeYHB">The intervention group had access to the app and also received weekly SMS text message or email reminders to use the app whereas the control group received app only.</s><s xml:id="_cRyvnR7">At the end of the 8-week intervention, both groups showed an increase in symptom burden after AI initiation; although the increase was less in the intervention group, it did not reach a statistical significance.</s><s xml:id="_dyZmTQu">The intervention group reported higher AI adherence and higher weekly app use <ref type="bibr" target="#b65">[66]</ref>.</s></p><p xml:id="_xNcTdvw"><s xml:id="_B95xXch">Fu et al <ref type="bibr" target="#b57">[58]</ref> focused on lymphedema prevention and management.</s><s xml:id="_g4ygzVf">Breast cancer survivors (n=120) reporting pain or lymphedema symptoms were randomized to 1 of 2 web-and mobile-based programs.</s><s xml:id="_TdWgMWW">The intervention group received a program called The-Optimal-Lymph-Flow (TOLF), which included web-based educational information and lymphatic exercises as well as an mHealth app for performing the exercises on the go.</s><s xml:id="_3hHTvMk">The control group received an arm precaution program with web-based information on precautionary lifestyle behaviors as well as mobility exercises, also accessible via an mHealth app.</s><s xml:id="_9Ebrhny">At the end of the 12-week intervention, the TOLF group reported significantly fewer cases and less severity of chronic pain than the arm precaution group.</s><s xml:id="_fVTEGKe">Furthermore, the TOLF group reported significantly fewer cases of arm or hand swelling, heaviness, redness, and limited mobility in the arm and shoulder.</s><s xml:id="_sN4PfxH">However, neither the mean number of lymphedema symptoms nor the cases of general bodily pain differed between the groups.</s><s xml:id="_aaehrWS">Significant improvements were observed in QOL measurements in both groups <ref type="bibr" target="#b57">[58]</ref>.</s></p><p xml:id="_J99Fe97"><s xml:id="_F2eeEGx">The study by Visser et al <ref type="bibr" target="#b64">[65]</ref>, which included 122 breast cancer survivors, focused on psychosocial support and the efficacy of group medical consultations (GMCs).</s><s xml:id="_j8qVsxK">Participants were randomized to receive face-to-face GMCs along with access to an mHealth app, myGMC, or care as usual.</s><s xml:id="_27skJTT">The intervention group received an iPad with the myGMC app, along with a video chat app (FaceTalk), a reading app with additional information (iBooks), and a contact information app.</s><s xml:id="_pVZANMA">The app included videos of interviews with breast cancer survivors.</s><s xml:id="_nHyRbBP">Online group support sessions were held via FaceTalk.</s><s xml:id="_n5uUeB5">No significant differences were observed between the intervention group and the control group in terms of measurements of distress, empowerment, cancer worry, or QOL; however, a small yet significant improvement was found in medication adherence in the intervention group.</s><s xml:id="_2AepRwb">The intervention group reported significantly more peer support in the face-to-face meetings than in the online group support meetings, and overall app satisfaction was low <ref type="bibr" target="#b64">[65]</ref>.</s></p><p xml:id="_WCKjQND"><s xml:id="_YvqbH5e">Only 2 (18%) of the 11 studies delivered an app-only intervention to breast cancer survivors.</s><s xml:id="_savMgsV">Çınar et al <ref type="bibr" target="#b58">[59]</ref> randomized 64 breast cancer survivors undergoing hormone therapy to an mHealth app intervention or a control group for 12 weeks.</s><s xml:id="_5SqFASA">The app featured educational content, relaxation techniques, and a symptom diary, as well as daily personalized reminders related to patient care.A positive impact was observed on the majority of the QOL measurements (FACT-ES) as well as a significant reduction in distress levels in the intervention group compared with the control group <ref type="bibr" target="#b58">[59]</ref>.</s><s xml:id="_xX6RkRq">Imai et al <ref type="bibr" target="#b63">[64]</ref>, who also delivered an app-only intervention, addressed the fear of recurrence.</s><s xml:id="_KQhcYuw">In their pilot study, 38 breast cancer survivors received problem-solving therapy (PST) through an mHealth app.</s><s xml:id="_5Qw5zy2">The app included sessions outlining PST and its principles and skills.</s><s xml:id="_YrrmN8v">After gaining an understanding of PST, the participants used a worksheet within the app to work on problems that were triggering a fear of recurrence.</s><s xml:id="_7expUTC">At the end of the 8-week intervention, overall fear of recurrence reduced significantly from baseline <ref type="bibr" target="#b63">[64]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_VbTa29T">Risk-of-Bias Assessment</head><p xml:id="_N33YURs"><s xml:id="_3XvsQWt">Studies that included a randomization element were scored using the Cochrane risk-of-bias tool.</s><s xml:id="_7Q6tt9m">The studies not included in the bias assessment were nonrandomized pilot and feasibility studies <ref type="bibr" target="#b61">[62]</ref><ref type="bibr" target="#b62">[63]</ref><ref type="bibr" target="#b63">[64]</ref> and a nonrandomized prospective cohort study <ref type="bibr" target="#b53">[54]</ref>.</s><s xml:id="_AaEMypp">In all studies (n=13), at least 1 domain was scored as high risk of bias or unclear risk of bias.</s><s xml:id="_2TEfg7c">Among the 13 studies, random sequence generation was scored as high risk of bias in 1 (8%) and unclear risk of bias in 4 (31%).</s><s xml:id="_bQTAGqX">Allocation concealment was scored inadequate or unclear risk of bias for the majority of the studies (9/13, 69%).</s><s xml:id="_CkVUV3U">Blinding of participants and personnel was not performed or unclear in 11 (85%) of the 13 assessed studies.</s><s xml:id="_buhnr9e">None of the studies were classified as high risk of bias for incomplete outcome data; however, 1 (8%) of the 13 studies was deemed to have an unclear risk of bias.</s><s xml:id="_VQtVhnD">No studies were deemed to have a high risk of bias for selective reporting.</s><s xml:id="_thS9rjA">Of the 13 studies, 2 (15%) were considered to have a high risk of bias for other sources of bias.</s><s xml:id="_tkQMJ9C">Risk of bias in multiple domains was present in the majority of the studies (8/13, 62%).</s><s xml:id="_CXKSjzx">The majority of the studies (10/13, 77%) were deemed to have an unclear risk of bias on at least 1 domain.</s><s xml:id="_cETeyS9">The results of the risk-of-bias assessment are presented in Figure 2 <ref type="bibr" target="#b50">[51]</ref><ref type="bibr" target="#b51">[52]</ref><ref type="bibr" target="#b52">[53]</ref><ref type="bibr" target="#b54">[55]</ref><ref type="bibr" target="#b55">[56]</ref><ref type="bibr" target="#b56">[57]</ref><ref type="bibr" target="#b57">[58]</ref><ref type="bibr" target="#b58">[59]</ref><ref type="bibr" target="#b59">[60]</ref><ref type="bibr" target="#b60">[61]</ref><ref type="bibr" target="#b64">[65]</ref><ref type="bibr" target="#b65">[66]</ref><ref type="bibr" target="#b66">[67]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_EwFPsvH">Discussion</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_dEGmArH">Principal Findings</head><p xml:id="_kGVg6ZV"><s xml:id="_uXq7y4X">This study synthesizes the literature on the effects of lifestyle interventions via mHealth apps on QOL and well-being in patients with breast cancer.</s><s xml:id="_jmRY94w">As digital interventions and health apps continue to grow in popularity, critical reviews of the available evidence in this field must follow with the aim of easily accessible, evidence-based, and clinically accepted DTx becoming available to all patients with breast cancer and survivors.</s><s xml:id="_mF8JjbK">A total of 17 studies were identified that delivered a lifestyle or behavioral intervention to patients with breast cancer or survivors with the support of a mobile app, including measurements of QOL or well-being.</s><s xml:id="_uM6ZCuB">All apps identified in the results were mHealth apps; however, none of the studies mentioned DTx, indicating that the interventions have not been through a regulated approval process.</s><s xml:id="_3mZaZhA">Overall, the results of the review indicate that mobile apps are a promising avenue for improving QOL and well-being in patients with breast cancer and survivors.</s></p><p xml:id="_DX7wcNu"><s xml:id="_tmMAu7e">All mobile app interventions delivered during active treatment resulted in some form of positive effect on QOL or well-being.</s><s xml:id="_WzmEN2B">The majority of the studies (5/6, 83%) focused on symptom management <ref type="bibr" target="#b51">[52]</ref><ref type="bibr" target="#b52">[53]</ref><ref type="bibr" target="#b53">[54]</ref><ref type="bibr" target="#b54">[55]</ref><ref type="bibr" target="#b55">[56]</ref>.</s><s xml:id="_U4sqgNN">Although some of the studies (2/6, 33%) included measurements for anxiety <ref type="bibr" target="#b54">[55,</ref><ref type="bibr" target="#b55">56]</ref>, only 1 (17%) of the 6 studies focused on mental health as the primary outcome <ref type="bibr" target="#b50">[51]</ref> and was the only study to observe a significant reduction in anxiety.</s><s xml:id="_qPPX3vZ">This may speak to a need for including mental health-focused elements in addition to symptom management when designing mHealth apps for patients with breast cancer.</s></p><p xml:id="_kvmctVS"><s xml:id="_vPUWKaa">Among the studies focusing on symptom management in patients with breast cancer, the majority (4/5, 80%) focused on patients undergoing chemotherapy <ref type="bibr" target="#b51">[52,</ref><ref type="bibr" target="#b53">[54]</ref><ref type="bibr" target="#b54">[55]</ref><ref type="bibr" target="#b55">[56]</ref>.</s><s xml:id="_KP76YPz">However, only 1 (25%) of these 4 studies specifically addressed women with metastatic breast cancer <ref type="bibr" target="#b55">[56]</ref>.</s><s xml:id="_mYvDjPG">This may point to a lack of available mobile apps that aim to improve QOL in women with advanced stage breast cancer.</s></p><p xml:id="_kAB9eu5"><s xml:id="_QqVj8bp">Although all studies delivering a mobile app intervention during active clinical care observed positive effects on QOL or well-being, only 1 (17%) of these 6 studies included a long-term follow-up period <ref type="bibr" target="#b54">[55]</ref>.</s><s xml:id="_jFvytmn">At 6 months after active treatment, no significant differences were observed between the intervention and control groups.</s><s xml:id="_eNSJNF6">Although self-efficacy improved and QOL reduction was less in the intervention group, the positive effects were not sustained after completion of chemotherapy <ref type="bibr" target="#b54">[55]</ref>.</s><s xml:id="_rcmjX2H">This may hint at either a need for continued support or an alternative intervention strategy after completion of chemotherapy.</s><s xml:id="_ydQ3pTw">Furthermore, not all interventions covered the full duration of active clinical treatment, which, combined with the lack of follow-up, means that the long-term effects of the mobile app interventions cannot be accurately predicted.</s><s xml:id="_FCGhUkx">Similarly, for breast cancer survivors, only 2 (18%) of the 11 studies included a follow-up period <ref type="bibr" target="#b60">[61,</ref><ref type="bibr" target="#b64">65]</ref>; of these 2 studies, 1 (50%) observed some sustained positive effect at the 2-week follow-up <ref type="bibr" target="#b60">[61]</ref>.</s><s xml:id="_GQpVGE7">This highlights the need to gain further knowledge of the long-term effects of mobile app-driven lifestyle interventions on QOL and well-being in patients with breast cancer and survivors.</s></p><p xml:id="_cDT2p24"><s xml:id="_N5EdkYY">Overall, the results for breast cancer survivors varied more so than those for patients with breast cancer.</s><s xml:id="_43XzZPJ">Of the 3 studies focusing primarily on PA <ref type="bibr" target="#b56">[57,</ref><ref type="bibr" target="#b59">60,</ref><ref type="bibr" target="#b66">67]</ref>, only 2 (67%) observed a significant positive effect on QOL <ref type="bibr" target="#b59">[60,</ref><ref type="bibr" target="#b66">67]</ref>; of these 2 studies, 1 (50%) also included an in-person rehabilitation program, to which some of the positive effects could be attributed <ref type="bibr" target="#b59">[60]</ref>.</s><s xml:id="_B6ejRnX">Improvements in QOL were also observed when the intervention combined multiple factors affecting QOL, such as PA, reduction of symptom burden, and nutrition <ref type="bibr" target="#b60">[61,</ref><ref type="bibr" target="#b61">62]</ref>.</s><s xml:id="_7FTb3fp">This might highlight a need for a multifaceted solution combining PA and symptom management strategies to improve QOL and well-being in breast cancer survivors.</s></p><p xml:id="_9ZXQ9nD"><s xml:id="_RUxcdz3">Of the 6 studies involving patients with breast cancer, 5 (83%) delivered an app-only intervention <ref type="bibr" target="#b51">[52]</ref><ref type="bibr" target="#b52">[53]</ref><ref type="bibr" target="#b53">[54]</ref><ref type="bibr" target="#b54">[55]</ref><ref type="bibr" target="#b55">[56]</ref>, whereas of the 11 studies identified as aiding breast cancer survivors, only 2 (18%) delivered an app-only intervention <ref type="bibr" target="#b58">[59,</ref><ref type="bibr" target="#b63">64]</ref>.</s><s xml:id="_F4T8Bvx">The remaining studies used various supporting materials in addition to the app, such as wearables <ref type="bibr" target="#b56">[57,</ref><ref type="bibr" target="#b61">62]</ref>, printed materials <ref type="bibr" target="#b61">[62]</ref>, non-app-based reminders <ref type="bibr" target="#b56">[57,</ref><ref type="bibr" target="#b62">63,</ref><ref type="bibr" target="#b65">66]</ref>, web-based information <ref type="bibr" target="#b57">[58,</ref><ref type="bibr" target="#b64">65]</ref>, non-app-based coaching or group support <ref type="bibr" target="#b50">[51,</ref><ref type="bibr" target="#b60">61,</ref><ref type="bibr" target="#b61">62,</ref><ref type="bibr" target="#b64">65]</ref>, and an in-person group rehabilitation program <ref type="bibr" target="#b59">[60]</ref>.</s><s xml:id="_fJMFeda">Ease of use has been identified as an important preference when it comes to mHealth interventions in breast cancer care <ref type="bibr" target="#b69">[70]</ref>.</s><s xml:id="_cEnV6Uu">Using multiple supporting materials, such as printed materials, a website, and an app, could cause participants to feel overwhelmed or confused as to where to seek information and support.</s><s xml:id="_xPatnE5">Considering that undergoing and recovering from breast cancer treatment can cause psychological distress <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b7">8]</ref>, it is important to avoid potentially adding to this distress with overly complicated intervention materials.</s><s xml:id="_ZJC42wD">In addition, spreading out the information across multiple sources may lead to confusion, reduced motivation, and ultimately reduced long-term adherence.</s><s xml:id="_Hj9VsCj">Furthermore, the majority of the studies (8/10, 80%) observed positive effects on QOL or well-being variables <ref type="bibr" target="#b57">[58]</ref><ref type="bibr" target="#b58">[59]</ref><ref type="bibr" target="#b59">[60]</ref><ref type="bibr" target="#b60">[61]</ref><ref type="bibr" target="#b61">[62]</ref><ref type="bibr" target="#b62">[63]</ref><ref type="bibr" target="#b63">[64]</ref><ref type="bibr" target="#b66">67]</ref>; however, because of the various supporting materials used, the positive effects observed cannot be attributed to the mHealth apps alone.</s><s xml:id="_WdPCcBP">Equally, it may be worth researching which supporting materials could be incorporated into the app to aid ease of use.</s><s xml:id="_xCYdvCf">An important aspect is also the design of the mHealth app itself.</s><s xml:id="_NhvAgkT">A successful mobile intervention for breast cancer is dependent upon collaboration among the designers, patients, and various health professionals, including nurses <ref type="bibr" target="#b70">[71]</ref>.</s></p><p xml:id="_4BSgTPN"><s xml:id="_bzqym9r">In the studies focusing on patients with breast cancer, all control groups received the usual standard of care.</s><s xml:id="_dEbY4bz">However, for breast cancer survivors, the condition for the control group, when there was one, differed greatly.</s><s xml:id="_c4xvDUU">Many of the control groups also received access to an mHealth app, either an alternative app (2/8, 25%) <ref type="bibr" target="#b57">[58,</ref><ref type="bibr" target="#b60">61]</ref> or the same app but without certain supporting materials (2/8, 25%) <ref type="bibr" target="#b59">[60,</ref><ref type="bibr" target="#b65">66]</ref>, and many observed an increase in QOL measures for both groups (3/8, 38%) <ref type="bibr" target="#b57">[58,</ref><ref type="bibr" target="#b59">60,</ref><ref type="bibr" target="#b60">61]</ref>.</s><s xml:id="_23vdA8M">However, this does warrant more research into identifying which aspects of the mobile app-driven interventions are the most effective in improving QOL and well-being as well as the ideal content for a placebo app.</s></p><p xml:id="_PcGZrpG"><s xml:id="_xzuBEM6">Intervention length varied, ranging from 3 to 12 weeks for patients with breast cancer and 6 to 12 weeks for breast cancer survivors.</s><s xml:id="_2zax2MS">All studies involving patients with breast cancer observed some positive effects on QOL or mental well-being, regardless of intervention length.</s><s xml:id="_zFJNzx3">In terms of breast cancer survivors, most of the studies (8/11, 73%) observed some positive effects on QOL or mental well-being.</s><s xml:id="_6DduBRz">The shortest intervention <ref type="bibr" target="#b60">[61]</ref> observed QOL improvements that were similar to those of the longer ones <ref type="bibr" target="#b57">[58,</ref><ref type="bibr" target="#b59">60,</ref><ref type="bibr" target="#b61">[62]</ref><ref type="bibr" target="#b62">[63]</ref><ref type="bibr" target="#b63">[64]</ref><ref type="bibr" target="#b66">67]</ref>.</s><s xml:id="_EqFRgqY">Further research is needed to determine the optimal intervention length during active treatment as well as the ideal length and focus of a long-term support program.</s><s xml:id="_6fuju4Q">This is the first review to focus on breast cancer-specific mobile apps and their effect on QOL.</s><s xml:id="_ydrqRr6">The review is based on a strict search strategy and a clear focus on lifestyle interventions and QOL.</s><s xml:id="_B3Bcdks">However, certain limitations need to be addressed.</s><s xml:id="_Hb3BETA">Only English-language articles were included; we neither performed a statistical analysis nor evaluated the studies for quality.</s><s xml:id="_U2vynNy">Furthermore, although the majority of the included studies (10/17, 59%) were RCTs, a number of them (5/17, 29%) were feasibility or pilot studies <ref type="bibr" target="#b60">[61]</ref><ref type="bibr" target="#b61">[62]</ref><ref type="bibr" target="#b62">[63]</ref><ref type="bibr" target="#b63">[64]</ref><ref type="bibr" target="#b65">66]</ref>, which limits the strength of the results.</s><s xml:id="_hzqupGj">The studies that included a randomization element were assessed for risk of bias, and the assessment revealed that the most common risk of bias identified was related to blinding.</s><s xml:id="_rHZXbyC">Blinding participants and researchers to allocation to study group is challenging in the case of a lifestyle intervention, in particular because knowledge of the optimum dose of such interventions is not known.</s><s xml:id="_B57dXWZ">Thus, designing a placebo version of a mobile app may not be feasible, and blinding may therefore be difficult.</s><s xml:id="_p8QMyun">Despite the limitations of this review, the results indicate that the use of mobile apps to improve QOL and well-being in patients with breast cancer and survivors is promising.</s><s xml:id="_sNTChxR">Further research that includes mental health and psychosocial components is needed.</s><s xml:id="_jWe6wsK">In addition, further research delivering mobile app interventions without supporting materials is needed to fully determine the effectiveness of such apps.</s><s xml:id="_xTjSrx4">Future research would benefit from investigating long-term effects of mobile app-delivered lifestyle interventions in both patients with breast cancer and survivors.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_NY4r2X3">Conclusions</head><p xml:id="_3f4XT7x"><s xml:id="_kzWb9t4">On the basis of this new and updated synthesis of current research on mobile apps for QOL and well-being in breast cancer care, suggestive conclusions can be drawn despite limitations owing to methodological differences of the studies.</s><s xml:id="_y5BZw5e">In particular, positive effects on QOL were observed in patients undergoing active treatment in all reviewed studies, whereas the effects were less clear in the months after chemotherapy and in long-term survivors.</s><s xml:id="_JBXUcku">This may indicate a need for better understanding of patient needs when developing mHealth interventions for long-term survivors in terms of personalized approaches and adaptive therapies that can adjust to the changing needs of cancer survivors.</s><s xml:id="_ffy5a8f">Lifestyle and behavioral digital interventions are still being developed, and future solutions may become more sophisticated; however, the available data suggest that current mHealth apps aid patients with breast cancer and survivors and that the likelihood of adverse effects is low.</s><s xml:id="_QpETTTa">Therefore, although research and improvements should still be pursued, the use of mHealth solutions in breast cancer care should be encouraged because they provide a cost-effective and accessible way to improve QOL and well-being.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p xml:id="_WTyEb7y"><s xml:id="_vdU9RYm">Figure 1.</s><s xml:id="_tQXPxth">Flow diagram of the identification, screening, and inclusion of studies for review.</s><s xml:id="_h2wXs9Q">QOL: quality of life; RCT: randomized controlled trial.</s></p></div></figDesc><graphic coords="4,56.69,82.34,481.89,301.18" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc><div><p xml:id="_wpUJxjt"><s xml:id="_q4J2VbK">Figure 2. Assessment of risk of bias using the Cochrane Collaboration's tool [51-53,55-61,65-67].</s><s xml:id="_bBW47Dg">Green: low risk of bias, red: high risk of bias, and orange: unclear risk of bias.</s></p></div></figDesc><graphic coords="14,56.69,92.54,481.89,142.56" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_HEXmTca"><s xml:id="_sv49S2n">Description of study characteristics.</s></p></div></figDesc><table><row><cell>Study, year</cell><cell>Study design</cell><cell>Location, study</cell><cell>Intervention description,</cell><cell>Measurements</cell><cell>Control condition</cell><cell>Key outcomes</cell></row><row><cell></cell><cell></cell><cell>population, and</cell><cell>duration, and follow-up</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>number of partici-</cell><cell>(when applicable)</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>pants (n)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_ecmAYAE"><s xml:id="_hjUgUAX">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1"><p xml:id="_KEAFUzA"><s xml:id="_F6qNQCC">J Med Internet Res 2023 | vol. 25 | e42852 | p. 3 https://www.jmir.org/2023/1/e42852</s><s xml:id="_HMStcB8">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_2"><p xml:id="_XreGedE"><s xml:id="_bc4cbBd">J Med Internet Res 2023 | vol. 25 | e42852 | p. 4 https://www.jmir.org/2023/1/e42852</s><s xml:id="_ZDHpQPr">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_3"><p xml:id="_pAPdTA2"><s xml:id="_bwkwhfH">J Med Internet Res 2023 | vol. 25 | e42852 | p. 5 https://www.jmir.org/2023/1/e42852</s><s xml:id="_ZWrGYyU">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_4"><p xml:id="_VXn3CqN"><s xml:id="_h7pXmgH">J Med Internet Res 2023 | vol. 25 | e42852 | p. 14 https://www.jmir.org/2023/1/e42852</s><s xml:id="_jBgQvS2">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_5"><p xml:id="_jGS5pNU"><s xml:id="_ReFKknE">J Med Internet Res 2023 | vol. 25 | e42852 | p. 19 https://www.jmir.org/2023/1/e42852</s><s xml:id="_MS4bVKD">(page number not for citation purposes)</s></p></note>
		</body>
		<back>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_T2AadNd">Data Availability</head><p xml:id="_WPV4AHw"><s xml:id="_t6bWjPn">The protocol and other material can be provided upon reasonable request.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_XZtpQNs">Conflicts of Interest</head><p xml:id="_RsjXvat"><s xml:id="_VUJGyuV">SLG is an employee of Sidekick Health.</s><s xml:id="_pgezY32">All other authors declare no other conflicts of interest.</s><s xml:id="_gP2fVec">©Saeunn Rut Saevarsdottir, Sigridur Lara Gudmundsdottir.</s><s xml:id="_tNqRp4n">Originally published in the Journal of Medical Internet Research (<ref type="url" target="https://www.jmir.org">https://www.jmir.org</ref>),</s><s xml:id="_3h4bH9x">26.07.2023.</s><s xml:id="_MD44tKy">This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ref type="url" target="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ref>),</s><s xml:id="_R49z2EW">which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited.</s><s xml:id="_pZrbbf4">The complete bibliographic information, a link to the original publication on <ref type="url" target="https://www.jmir.org/">https://www.jmir.org/</ref>,</s><s xml:id="_nYj5kAD">as well as this copyright and license information must be included.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_jsMCRAf">Multimedia Appendix 1</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_cG3TY3F">Electronic address: clinicESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.orgalguidelines@esmo.org. Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up</title>
		<author>
			<persName><forename type="first">F</forename><surname>Cardoso</surname></persName>
			<affiliation>
				<orgName type="collaboration">ESMO Guidelines Committee</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kyriakides</surname></persName>
			<affiliation>
				<orgName type="collaboration">ESMO Guidelines Committee</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ohno</surname></persName>
			<affiliation>
				<orgName type="collaboration">ESMO Guidelines Committee</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Penault-Llorca</surname></persName>
			<affiliation>
				<orgName type="collaboration">ESMO Guidelines Committee</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Poortmans</surname></persName>
			<affiliation>
				<orgName type="collaboration">ESMO Guidelines Committee</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">T</forename><surname>Rubio</surname></persName>
			<affiliation>
				<orgName type="collaboration">ESMO Guidelines Committee</orgName>
			</affiliation>
		</author>
		<idno type="DOI">10.1093/annonc/mdz173</idno>
		<idno>Medline: 31161190</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mNVGPZW">Ann Oncol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1194" to="1220" />
			<date type="published" when="2019-08-01">2019 Aug 01</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio IT, ESMO Guidelines Committee. Electronic address: clinicESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.orgalguidelines@esmo.org. Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2019 Aug 01;30(8):1194-1220 [FREE Full text] [doi: 10.1093/annonc/mdz173] [Medline: 31161190]</note>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<idno type="DOI">10.4324/9780203875773-8</idno>
		<ptr target="https://www.oecd-ilibrary.org/sites/c63a671a-en/index.html?itemId=/content/component/c63a671a-en#:~:text=For%20women%20diagnosed%20at%20an" />
		<title level="m" xml:id="_quSYDSS">Organisation for Economic Co-operation and Development</title>
		<imprint>
			<date type="published" when="2022-03-21">38%25%20. Figure%206.21. 2022-03-18</date>
		</imprint>
	</monogr>
	<note>Breast cancer outcomes</note>
	<note type="raw_reference">Breast cancer outcomes. Organisation for Economic Co-operation and Development. URL: https://www.oecd-ilibrary.org/ sites/c63a671a-en/index.html?itemId=/content/component/ c63a671a-en#:~:text=For%20women%20diagnosed%20at%20an,38%25%20(Figure%206.21) [accessed 2022-03-18]</note>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<author>
			<persName><forename type="first">M</forename><surname>Hewitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Ganz</surname></persName>
		</author>
		<idno type="DOI">10.1037/e720092007-001</idno>
		<title level="m" xml:id="_eKnCHpU">From Cancer Patient to Cancer Survivor: Lost in Transition</title>
		<meeting><address><addrLine>Washington, DC, USA</addrLine></address></meeting>
		<imprint>
			<publisher>The National Academies Press</publisher>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hewitt M, Ganz PA. From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC, USA: The National Academies Press; 2006.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<monogr>
		<title level="m" type="main" xml:id="_nX2hBHK">Cancer Treatment and Survivorship Facts and Figures 2019-2021</title>
		<idno type="DOI">10.1037/e720112007-001</idno>
		<ptr target="https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-treatment-and-survivorship-facts-and-figures/cancer-treatment-and-survivorship-facts-and-figures-2019-2021.pdf" />
		<imprint>
			<date type="published" when="2019">2019. 2022-03-18</date>
			<publisher>American Cancer Society</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Cancer Treatment and Survivorship Facts and Figures 2019-2021. American Cancer Society. 2019. URL: https://www. cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-treatment-and-survivorship-facts-and-figures/ cancer-treatment-and-survivorship-facts-and-figures-2019-2021.pdf [accessed 2022-03-18]</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_SJ9ZuUC">Chronic pain and other symptoms among breast cancer survivors: prevalence, predictors, and effects on quality of life</title>
		<author>
			<persName><forename type="first">R</forename><surname>Hamood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hamood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Merhasin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Keinan-Boker</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10549-017-4485-0</idno>
		<idno>Medline: 28861642</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pAxFcve">Breast Cancer Res Treat</title>
		<imprint>
			<biblScope unit="volume">167</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="157" to="169" />
			<date type="published" when="2018-01">2018 Jan</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hamood R, Hamood H, Merhasin I, Keinan-Boker L. Chronic pain and other symptoms among breast cancer survivors: prevalence, predictors, and effects on quality of life. Breast Cancer Res Treat 2018 Jan;167(1):157-169 [doi: 10.1007/s10549-017-4485-0] [Medline: 28861642]</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_ZySwy5R">Quality of life, problems, and needs of disease-free breast cancer survivors 5 years after diagnosis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wiskemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Steindorf</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11136-018-1866-8</idno>
		<idno>Medline: 29740782</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EKKj5BC">Qual Life Res</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="2077" to="2086" />
			<date type="published" when="2018-08">2018 Aug</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Schmidt ME, Wiskemann J, Steindorf K. Quality of life, problems, and needs of disease-free breast cancer survivors 5 years after diagnosis. Qual Life Res 2018 Aug;27(8):2077-2086 [doi: 10.1007/s11136-018-1866-8] [Medline: 29740782]</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_Pk5vdmt">Late effects of breast cancer treatment and potentials for rehabilitation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ewertz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Jensen</surname></persName>
		</author>
		<idno type="DOI">10.3109/0284186X.2010.533190</idno>
		<idno>Medline: 21231780</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ecMKghU">Acta Oncol</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="187" to="193" />
			<date type="published" when="2011-03">2011 Mar</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ewertz M, Jensen AB. Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol 2011 Mar;50(2):187-193 [doi: 10.3109/0284186X.2010.533190] [Medline: 21231780]</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_nUyN6Rg">Associations between breast cancer survivorship and adverse mental health outcomes: a systematic review</title>
		<author>
			<persName><forename type="first">H</forename><surname>Carreira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Müller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Harewood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Stanway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bhaskaran</surname></persName>
		</author>
		<idno type="DOI">10.1093/jnci/djy177</idno>
		<idno>Medline: 30403799</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6YQuR59">J Natl Cancer Inst</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1311" to="1327" />
			<date type="published" when="2018-12-01">2018 Dec 01</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Carreira H, Williams R, Müller M, Harewood R, Stanway S, Bhaskaran K. Associations between breast cancer survivorship and adverse mental health outcomes: a systematic review. J Natl Cancer Inst 2018 Dec 01;110(12):1311-1327 [FREE Full text] [doi: 10.1093/jnci/djy177] [Medline: 30403799]</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_rFVyXDh">Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Mcneely</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Rowe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Klassen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mackey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Courneya</surname></persName>
		</author>
		<idno type="DOI">10.1503/cmaj.051073</idno>
		<idno>Medline: 16818906</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GE3ASaK">CMAJ</title>
		<imprint>
			<biblScope unit="volume">175</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="34" to="41" />
			<date type="published" when="2006-07-04">2006 Jul 04</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ 2006 Jul 04;175(1):34-41 [FREE Full text] [doi: 10.1503/cmaj.051073] [Medline: 16818906]</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_cEaeHwG">The effects of diet and dietary interventions on the quality of life among breast cancer survivors: a cross-sectional analysis and a systematic review of experimental studies</title>
		<author>
			<persName><forename type="first">M</forename><surname>Barchitta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Maugeri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Magnano</forename><surname>San Lio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Quattrocchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Degrassi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Catalano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename></persName>
		</author>
		<idno type="DOI">10.3390/cancers12020322</idno>
		<idno>Medline: 32019093</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_84gx8A6">Cancers</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">322</biblScope>
			<date type="published" when="2020-01-30">2020 Jan 30</date>
			<pubPlace>Basel</pubPlace>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Barchitta M, Maugeri A, Magnano San Lio R, Quattrocchi A, Degrassi F, Catalano F, et al. The effects of diet and dietary interventions on the quality of life among breast cancer survivors: a cross-sectional analysis and a systematic review of experimental studies. Cancers (Basel) 2020 Jan 30;12(2):322 [FREE Full text] [doi: 10.3390/cancers12020322] [Medline: 32019093]</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_k8WMTjN">Effects of exercise on quality of life in women living with breast cancer: a systematic review</title>
		<author>
			<persName><forename type="first">D</forename><surname>Bicego</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ruddick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Storey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Harris</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1524-4741.2008.00670.x</idno>
		<idno>Medline: 19120381</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_m5gFjBe">Breast J</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="45" to="51" />
			<date type="published" when="2009-01">2009 Jan</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bicego D, Brown K, Ruddick M, Storey D, Wong C, Harris SR. Effects of exercise on quality of life in women living with breast cancer: a systematic review. Breast J 2009 Jan;15(1):45-51 [doi: 10.1111/j.1524-4741.2008.00670.x] [Medline: 19120381]</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_rkctsDk">Mindfulness-based stress reduction for breast cancer-a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">H</forename><surname>Cramer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lauche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Paul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Dobos</surname></persName>
		</author>
		<idno type="DOI">10.3747/co.19.1016</idno>
		<idno>Medline: 23144582</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nzgAGwB">Curr Oncol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="343" to="e352" />
			<date type="published" when="2012-10">2012 Oct</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Cramer H, Lauche R, Paul A, Dobos G. Mindfulness-based stress reduction for breast cancer-a systematic review and meta-analysis. Curr Oncol 2012 Oct;19(5):e343-e352 [FREE Full text] [doi: 10.3747/co.19.1016] [Medline: 23144582]</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_fY3aMcm">Mindfulness-based interventions for women with breast cancer: an updated systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">H</forename><surname>Haller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Winkler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Klose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Dobos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kümmel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Cramer</surname></persName>
		</author>
		<idno type="DOI">10.1080/0284186X.2017.1342862</idno>
		<idno>Medline: 28686520</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_bK3wqNM">Acta Oncol</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1665" to="1676" />
			<date type="published" when="2017-12">2017 Dec</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Haller H, Winkler MM, Klose P, Dobos G, Kümmel S, Cramer H. Mindfulness-based interventions for women with breast cancer: an updated systematic review and meta-analysis. Acta Oncol 2017 Dec;56(12):1665-1676 [doi: 10.1080/0284186X.2017.1342862] [Medline: 28686520]</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_f5ZcvxF">Effects of mindfulness-based therapy for patients with breast cancer: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ctim.2016.02.012</idno>
		<idno>Medline: 27261975</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4McT5mk">Complement Ther Med</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1" to="10" />
			<date type="published" when="2016-06">2016 Jun</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zhang J, Xu R, Wang B, Wang J. Effects of mindfulness-based therapy for patients with breast cancer: a systematic review and meta-analysis. Complement Ther Med 2016 Jun;26:1-10 [doi: 10.1016/j.ctim.2016.02.012] [Medline: 27261975]</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_uGWYPFy">Physical activity in breast cancer survivors: a systematic review and meta-analysis on overall and breast cancer survival</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Spei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Samoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bravi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">La</forename><surname>Vecchia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bamia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Benetou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.breast.2019.02.001</idno>
		<idno>Medline: 30780085</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_zuFJTjt">Breast</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="144" to="152" />
			<date type="published" when="2019-04">2019 Apr</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Spei ME, Samoli E, Bravi F, La Vecchia C, Bamia C, Benetou V. Physical activity in breast cancer survivors: a systematic review and meta-analysis on overall and breast cancer survival. Breast 2019 Apr;44:144-152 [doi: 10.1016/j.breast.2019.02.001] [Medline: 30780085]</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_aZysuAK">Physical activity before, during, and after chemotherapy for high-risk breast cancer: relationships with survival</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Cannioto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hutson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dighe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Mccann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Mccann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Zirpoli</surname></persName>
		</author>
		<idno type="DOI">10.1093/jnci/djaa046</idno>
		<idno>Medline: 32239145</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vP8FRV4">J Natl Cancer Inst</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="54" to="63" />
			<date type="published" when="2021-01-04">2021 Jan 04</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Cannioto RA, Hutson A, Dighe S, McCann W, McCann SE, Zirpoli GR, et al. Physical activity before, during, and after chemotherapy for high-risk breast cancer: relationships with survival. J Natl Cancer Inst 2021 Jan 04;113(1):54-63 [FREE Full text] [doi: 10.1093/jnci/djaa046] [Medline: 32239145]</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_qTqEjbt">Physical activity, exercise and breast cancer -what is the evidence for rehabilitation, aftercare, and survival? A review</title>
		<author>
			<persName><forename type="first">P</forename><surname>Wirtz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">T</forename><surname>Baumann</surname></persName>
		</author>
		<idno type="DOI">10.1159/000488717</idno>
		<idno>Medline: 29887785</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FqfXD5e">Breast Care</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="93" to="101" />
			<date type="published" when="2018-04">2018 Apr</date>
			<pubPlace>Basel</pubPlace>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Wirtz P, Baumann FT. Physical activity, exercise and breast cancer -what is the evidence for rehabilitation, aftercare, and survival? A review. Breast Care (Basel) 2018 Apr;13(2):93-101 [FREE Full text] [doi: 10.1159/000488717] [Medline: 29887785]</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_x6HXXDt">The effect of exercise on fatigue and physical functioning in breast cancer patients during and after treatment and at 6 months follow-up: a meta-analysis</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Juvet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Thune</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">K</forename><surname>Elvsaas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Fors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lundgren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bertheussen</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.breast.2017.04.003</idno>
		<idno>Medline: 28415013</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3s7SUNC">Breast</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="166" to="177" />
			<date type="published" when="2017-06">2017 Jun</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Juvet LK, Thune I, Elvsaas IK, Fors EA, Lundgren S, Bertheussen G, et al. The effect of exercise on fatigue and physical functioning in breast cancer patients during and after treatment and at 6 months follow-up: a meta-analysis. Breast 2017 Jun;33:166-177 [doi: 10.1016/j.breast.2017.04.003] [Medline: 28415013]</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_TJkwheQ">Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment</title>
		<author>
			<persName><forename type="first">H</forename><surname>Greenlee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Dupont-Reyes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Balneaves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Carlson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Deng</surname></persName>
		</author>
		<idno type="DOI">10.3322/caac.21397</idno>
		<idno>Medline: 28436999</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9UuANX6">CA Cancer J Clin</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="194" to="232" />
			<date type="published" when="2017-05-06">2017 May 06</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Greenlee H, DuPont-Reyes MJ, Balneaves LG, Carlson LE, Cohen MR, Deng G, et al. Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA Cancer J Clin 2017 May 06;67(3):194-232 [FREE Full text] [doi: 10.3322/caac.21397] [Medline: 28436999]</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_89QS4Ed">Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer</title>
		<author>
			<persName><forename type="first">H</forename><surname>Cramer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lauche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Klose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lange</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Langhorst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Dobos</surname></persName>
		</author>
		<idno type="DOI">10.1002/14651858.cd010802.pub2</idno>
		<idno>Medline: 28045199</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mWtxYNT">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">10802</biblScope>
			<date type="published" when="2017-01-03">2017 Jan 03</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Cramer H, Lauche R, Klose P, Lange S, Langhorst J, Dobos GJ. Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer. Cochrane Database Syst Rev 2017 Jan 03;1(1):CD010802 [FREE Full text] [doi: 10.1002/14651858.CD010802.pub2] [Medline: 28045199]</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_y7fNTE3">Mindfulness-based stress reduction among breast cancer survivors: a literature review and discussion</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Matchim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Armer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Stewart</surname></persName>
		</author>
		<idno type="DOI">10.1188/11.ONF.E61-E71</idno>
		<idno>Medline: 21356643</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WtQSHQc">Oncol Nurs Forum</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="61" to="E71" />
			<date type="published" when="2011-03">2011 Mar</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Matchim Y, Armer JM, Stewart BR. Mindfulness-based stress reduction among breast cancer survivors: a literature review and discussion. Oncol Nurs Forum 2011 Mar;38(2):E61-E71 [doi: 10.1188/11.ONF.E61-E71] [Medline: 21356643]</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_4XhhbQr">The efficacy of mindfulness-based stress reduction on mental health of breast cancer patients: a meta-analysis</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">Z</forename><surname>Zainal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Booth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Huppert</surname></persName>
		</author>
		<idno type="DOI">10.1002/pon.3171</idno>
		<idno>Medline: 22961994</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_t7CbWX8">Psychooncology</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1457" to="1465" />
			<date type="published" when="2013-07">2013 Jul</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zainal NZ, Booth S, Huppert FA. The efficacy of mindfulness-based stress reduction on mental health of breast cancer patients: a meta-analysis. Psychooncology 2013 Jul;22(7):1457-1465 [doi: 10.1002/pon.3171] [Medline: 22961994]</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_Z7jXghc">Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Hershman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Shao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Kushi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Buono</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">Y</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fehrenbacher</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10549-010-1132-4</idno>
		<idno>Medline: 20803066</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cyVMraj">Breast Cancer Res Treat</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="529" to="537" />
			<date type="published" when="2011-04">2011 Apr</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Hershman DL, Shao T, Kushi LH, Buono D, Tsai WY, Fehrenbacher L, et al. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 2011 Apr;126(2):529-537 [FREE Full text] [doi: 10.1007/s10549-010-1132-4] [Medline: 20803066]</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_YZuHYdr">Adherence to endocrine therapy for breast cancer</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Chlebowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Geller</surname></persName>
		</author>
		<idno type="DOI">10.1159/000100444</idno>
		<idno>Medline: 17344666</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JnGfGYQ">Oncology</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="1" to="9" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chlebowski RT, Geller ML. Adherence to endocrine therapy for breast cancer. Oncology 2006;71(1-2):1-9 [doi: 10.1159/000100444] [Medline: 17344666]</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_6XbaJSy">Interventions to promote adherence to endocrine therapy among breast cancer survivors: a meta-analysis</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Finitsis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Vose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Mahalak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Salner</surname></persName>
		</author>
		<idno type="DOI">10.1002/pon.4959</idno>
		<idno>Medline: 30511789</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_QqbeP9w">Psychooncology</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="255" to="263" />
			<date type="published" when="2019-03">2019 Mar</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Finitsis DJ, Vose BA, Mahalak JG, Salner AL. Interventions to promote adherence to endocrine therapy among breast cancer survivors: a meta-analysis. Psychooncology 2019 Mar;28(2):255-263 [doi: 10.1002/pon.4959] [Medline: 30511789]</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_5pcJGeK">The increasing value of eHealth in the delivery of patient-centred cancer care</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Penedo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Oswald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Kronenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Garcia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Cella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Yanez</surname></persName>
		</author>
		<idno type="DOI">10.1016/s1470-2045(20)30021-8</idno>
		<idno>Medline: 32359500</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DG2x4Yd">Lancet Oncol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="240" to="e251" />
			<date type="published" when="2020-05">2020 May</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Penedo FJ, Oswald LB, Kronenfeld JP, Garcia SF, Cella D, Yanez B. The increasing value of eHealth in the delivery of patient-centred cancer care. Lancet Oncol 2020 May;21(5):e240-e251 [FREE Full text] [doi: 10.1016/S1470-2045(20)30021-8] [Medline: 32359500]</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_MbTZB9h">Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives</title>
		<author>
			<persName><forename type="first">M</forename><surname>Aapro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bossi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dasari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fallowfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gascón</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Geller</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00520-020-05539-1</idno>
		<idno>Medline: 32533435</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WyFfxBM">Support Care Cancer</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="4589" to="4612" />
			<date type="published" when="2020-10">2020 Oct</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Aapro M, Bossi P, Dasari A, Fallowfield L, Gascón P, Geller M, et al. Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives. Support Care Cancer 2020 Oct;28(10):4589-4612 [FREE Full text] [doi: 10.1007/s00520-020-05539-1] [Medline: 32533435]</note>
</biblStruct>

<biblStruct xml:id="b27">
	<monogr>
		<title level="m" type="main" xml:id="_btS6fhJ">mHealth: new horizons for health through mobile technologies: second global survey on eHealth</title>
		<ptr target="-04-04" />
		<imprint>
			<date type="published" when="2011">2011. 2022</date>
			<publisher>World Health Organization</publisher>
		</imprint>
		<respStmt>
			<orgName>WHO Global Observatory for eHealth</orgName>
		</respStmt>
	</monogr>
	<note type="raw_reference">WHO Global Observatory for eHealth. mHealth: new horizons for health through mobile technologies: second global survey on eHealth. World Health Organization. 2011. URL: https://apps.who.int/iris/handle/10665/44607 [accessed 2022-04-04]</note>
</biblStruct>

<biblStruct xml:id="b28">
	<monogr>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">R</forename><surname>Grand</surname></persName>
		</author>
		<idno type="DOI">10.1016/s1364-5439(15)30080-0</idno>
		<ptr target="https://www.grandviewresearch.com/industry-analysis/mhealth-app-market" />
		<title level="m" xml:id="_jEJM9HA">mHealth apps market size and share report</title>
		<imprint>
			<publisher>Grand View Research</publisher>
			<date type="published" when="2022-04-04">2022-2030. 2022-04-04</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Grand VR. mHealth apps market size and share report, 2022-2030. Grand View Research. URL: https://www. grandviewresearch.com/industry-analysis/mhealth-app-market [accessed 2022-04-04]</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_k24wDYJ">Digital therapeutics-what they are, what they will be</title>
		<author>
			<persName><forename type="first">G</forename><surname>Recchia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Maria</forename><surname>Capuano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mistri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Verna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
		<idno type="DOI">10.31080/asms.2020.04.0575</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3TFHkDW">Act Scie Medic</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1" to="9" />
			<date type="published" when="2020-02-26">2020 Feb 26</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Recchia G, Maria Capuano D, Mistri N, Verna R. Digital therapeutics-what they are, what they will be. Act Scie Medic 2020 Feb 26;4(3):1-9 [FREE Full text] [doi: 10.31080/asms.2020.04.0575]</note>
</biblStruct>

<biblStruct xml:id="b30">
	<monogr>
		<title level="m" type="main" xml:id="_Wr2qsac">Digital therapeutics definition and core principles</title>
		<ptr target="https://dtxalliance.org/wp-content/uploads/2021/01/DTA_DTx-Definition-and-Core-Principles.pdf" />
		<imprint>
			<date type="published" when="2019">2019. 2022-03-20</date>
			<publisher>Digital Therapeutics Alliance</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Digital therapeutics definition and core principles. Digital Therapeutics Alliance. 2019. URL: https://dtxalliance.org/ wp-content/uploads/2021/01/DTA_DTx-Definition-and-Core-Principles.pdf [accessed 2022-03-20]</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_sDF6uqN">Role of digital therapeutics and the changing future of healthcare</title>
		<author>
			<persName><forename type="first">A</forename><surname>Dang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Arora</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Rane</surname></persName>
		</author>
		<idno type="DOI">10.4103/jfmpc.jfmpc_105_20</idno>
		<idno>Medline: 32754475</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_K9UGDYq">J Family Med Prim Care</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="2207" to="2213" />
			<date type="published" when="2020-05">2020 May</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Dang A, Arora D, Rane P. Role of digital therapeutics and the changing future of healthcare. J Family Med Prim Care 2020 May;9(5):2207-2213 [FREE Full text] [doi: 10.4103/jfmpc.jfmpc_105_20] [Medline: 32754475]</note>
</biblStruct>

<biblStruct xml:id="b32">
	<monogr>
		<title level="m" type="main" xml:id="_DArHCv3">Smartphone users</title>
		<author>
			<persName><forename type="first">Dea</forename><forename type="middle">S</forename></persName>
		</author>
		<ptr target="https://www.statista.com/statistics/330695/number-of-smartphone-users-worldwide/" />
		<imprint>
			<date type="published" when="2022-04-05">2026. 2022-04-05</date>
			<publisher>Statista</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">O&apos;Dea S. Smartphone users 2026. Statista. URL: https://www.statista.com/statistics/330695/ number-of-smartphone-users-worldwide/ [accessed 2022-04-05]</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_RkednrB">What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Iribarren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Cato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Falzon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Stone</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0170581</idno>
		<idno>Medline: 28152012</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ytnhmgP">PLoS One</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">170581</biblScope>
			<date type="published" when="2017-02-02">2017 Feb 02</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Iribarren SJ, Cato K, Falzon L, Stone PW. What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions. PLoS One 2017 Feb 02;12(2):e0170581 [FREE Full text] [doi: 10.1371/journal.pone.0170581] [Medline: 28152012]</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_WgVyzsp">Patients&apos; perceptions of mHealth apps: meta-ethnographic review of qualitative studies</title>
		<author>
			<persName><forename type="first">V</forename><surname>Vo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Auroy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sarradon-Eck</surname></persName>
		</author>
		<idno type="DOI">10.2196/13817</idno>
		<idno>Medline: 31293246</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CDwKzsq">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page">13817</biblScope>
			<date type="published" when="2019-07-10">2019 Jul 10</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Vo V, Auroy L, Sarradon-Eck A. Patients&apos; perceptions of mHealth apps: meta-ethnographic review of qualitative studies. JMIR Mhealth Uhealth 2019 Jul 10;7(7):e13817 [FREE Full text] [doi: 10.2196/13817] [Medline: 31293246]</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_ahwyDfZ">The effectiveness of mHealth for self-management in improving pain, psychological distress, fatigue, and sleep in cancer survivors: a systematic review</title>
		<author>
			<persName><forename type="first">Hernandez</forename><surname>Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lawler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Langbecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
		<idno type="DOI">10.1007/s11764-018-0730-8</idno>
		<idno>Medline: 30635865</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UkjEYav">J Cancer Surviv</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="97" to="107" />
			<date type="published" when="2019-03">2019 Mar</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hernandez Silva E, Lawler S, Langbecker D. The effectiveness of mHealth for self-management in improving pain, psychological distress, fatigue, and sleep in cancer survivors: a systematic review. J Cancer Surviv 2019 Mar;13(1):97-107 [doi: 10.1007/s11764-018-0730-8] [Medline: 30635865]</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_Gek6rwB">Do mHealth applications improve clinical outcomes of patients with cancer? A critical appraisal of the peer-reviewed literature</title>
		<author>
			<persName><forename type="first">J</forename><surname>Osborn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ajakaiye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Cooksley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Subbe</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00520-019-04945-4</idno>
		<idno>Medline: 31273501</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xtJRpB7">Support Care Cancer</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1469" to="1479" />
			<date type="published" when="2020-03">2020 Mar</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Osborn J, Ajakaiye A, Cooksley T, Subbe CP. Do mHealth applications improve clinical outcomes of patients with cancer? A critical appraisal of the peer-reviewed literature. Support Care Cancer 2020 Mar;28(3):1469-1479 [FREE Full text] [doi: 10.1007/s00520-019-04945-4] [Medline: 31273501]</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_fPcXYs7">Can mHealth interventions improve quality of life of cancer patients? A systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">I</forename><surname>Buneviciene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Mekary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Onnela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bunevicius</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.critrevonc.2020.103123</idno>
		<idno>Medline: 33190065</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_NTaBKH7">Crit Rev Oncol Hematol</title>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="page">103123</biblScope>
			<date type="published" when="2021-01">2021 Jan</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Buneviciene I, Mekary RA, Smith TR, Onnela JP, Bunevicius A. Can mHealth interventions improve quality of life of cancer patients? A systematic review and meta-analysis. Crit Rev Oncol Hematol 2021 Jan;157:103123 [FREE Full text] [doi: 10.1016/j.critrevonc.2020.103123] [Medline: 33190065]</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_Qttx8GG">eHealth for improving quality of life in breast cancer patients: a systematic review</title>
		<author>
			<persName><forename type="first">S</forename><surname>Triberti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Savioni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Sebri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pravettoni</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ctrv.2019.01.003</idno>
		<idno>Medline: 30658289</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rcBS7rW">Cancer Treat Rev</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="1" to="14" />
			<date type="published" when="2019-03">2019 Mar</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Triberti S, Savioni L, Sebri V, Pravettoni G. eHealth for improving quality of life in breast cancer patients: a systematic review. Cancer Treat Rev 2019 Mar;74:1-14 [doi: 10.1016/j.ctrv.2019.01.003] [Medline: 30658289]</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_Fnp47YK">Mobile phone apps for quality of life and well-being assessment in breast and prostate cancer patients: systematic review</title>
		<author>
			<persName><forename type="first">E</forename><surname>Rincon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Monteiro-Guerra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Rivera-Romero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Dorronzoro-Zubiete</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Sanchez-Bocanegra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gabarron</surname></persName>
		</author>
		<idno type="DOI">10.2196/mhealth.8741</idno>
		<idno>Medline: 29203459</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JGYHVX8">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page">187</biblScope>
			<date type="published" when="2017-12-04">2017 Dec 04</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Rincon E, Monteiro-Guerra F, Rivera-Romero O, Dorronzoro-Zubiete E, Sanchez-Bocanegra CL, Gabarron E. Mobile phone apps for quality of life and well-being assessment in breast and prostate cancer patients: systematic review. JMIR Mhealth Uhealth 2017 Dec 04;5(12):e187 [FREE Full text] [doi: 10.2196/mhealth.8741] [Medline: 29203459]</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_sXSYdC6">Research-tested mobile apps for breast cancer care: systematic review</title>
		<author>
			<persName><forename type="first">C</forename><surname>Jongerius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Russo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mazzocco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pravettoni</surname></persName>
		</author>
		<idno type="DOI">10.2196/10930</idno>
		<idno>Medline: 30741644</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YAvhecH">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">e10930</biblScope>
			<date type="published" when="2019-03-11">2019 Mar 11</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Jongerius C, Russo S, Mazzocco K, Pravettoni G. Research-tested mobile apps for breast cancer care: systematic review. JMIR Mhealth Uhealth 2019 Mar 11;7(2):e10930 [FREE Full text] [doi: 10.2196/10930] [Medline: 30741644]</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_fgzhf9K">Advancing digital health innovation in oncology: priorities for high-value digital transformation in cancer care</title>
		<author>
			<persName><forename type="first">S</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Goldsack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cordovano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Downing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Fields</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Geoghegan</surname></persName>
		</author>
		<idno type="DOI">10.2196/43404</idno>
		<idno>Medline: 36598811</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_yrhxMPc">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page">43404</biblScope>
			<date type="published" when="2023-01-04">2023 Jan 04</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Patel S, Goldsack JC, Cordovano G, Downing A, Fields KK, Geoghegan C, et al. Advancing digital health innovation in oncology: priorities for high-value digital transformation in cancer care. J Med Internet Res 2023 Jan 04;25:e43404 [FREE Full text] [doi: 10.2196/43404] [Medline: 36598811]</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_fe4vFQ5">Systematic reviews and meta-analysis: understanding the best evidence in primary healthcare</title>
		<author>
			<persName><forename type="first">S</forename><surname>Gopalakrishnan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ganeshkumar</surname></persName>
		</author>
		<idno type="DOI">10.4103/2249-4863.109934</idno>
		<idno>Medline: 24479036</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dvMYGRJ">J Family Med Prim Care</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="9" to="14" />
			<date type="published" when="2013-01">2013 Jan</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Gopalakrishnan S, Ganeshkumar P. Systematic reviews and meta-analysis: understanding the best evidence in primary healthcare. J Family Med Prim Care 2013 Jan;2(1):9-14 [FREE Full text] [doi: 10.4103/2249-4863.109934] [Medline: 24479036]</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_k46phuJ">The Cochrane collaboration&apos;s tool for assessing risk of bias in randomised trials</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Higgins</surname></persName>
			<affiliation>
				<orgName type="collaboration">Cochrane Statistical Methods Group</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
			<affiliation>
				<orgName type="collaboration">Cochrane Statistical Methods Group</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Gøtzsche</surname></persName>
			<affiliation>
				<orgName type="collaboration">Cochrane Statistical Methods Group</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Jüni</surname></persName>
			<affiliation>
				<orgName type="collaboration">Cochrane Statistical Methods Group</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Moher</surname></persName>
			<affiliation>
				<orgName type="collaboration">Cochrane Statistical Methods Group</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Oxman</surname></persName>
			<affiliation>
				<orgName type="collaboration">Cochrane Statistical Methods Group</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">Cochrane</forename><surname>Bias</surname></persName>
			<affiliation>
				<orgName type="collaboration">Cochrane Statistical Methods Group</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">Methods</forename><surname>Group</surname></persName>
			<affiliation>
				<orgName type="collaboration">Cochrane Statistical Methods Group</orgName>
			</affiliation>
		</author>
		<idno type="DOI">10.1136/bmj.d5928</idno>
		<idno>Medline: 22008217</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qSkhRz6">BMJ</title>
		<imprint>
			<biblScope unit="volume">343</biblScope>
			<biblScope unit="page">5928</biblScope>
			<date type="published" when="2011-10-18">2011 Oct 18</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Cochrane Bias Methods Group, Cochrane Statistical Methods Group. The Cochrane collaboration&apos;s tool for assessing risk of bias in randomised trials. BMJ 2011 Oct 18;343:d5928 [FREE Full text] [doi: 10.1136/bmj.d5928] [Medline: 22008217]</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_cajNZUA">Feasibility of the mobile mindfulness-based stress reduction for breast cancer (mMBSR(BC)) program for symptom improvement among breast cancer survivors</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Lengacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Reich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ramesar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Alinat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Moscoso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cousin</surname></persName>
		</author>
		<idno type="DOI">10.1002/pon.4491</idno>
		<idno>Medline: 28665541</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rnuaZuP">Psychooncology</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="524" to="531" />
			<date type="published" when="2018-02">2018 Feb</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Lengacher CA, Reich RR, Ramesar S, Alinat CB, Moscoso M, Cousin L, et al. Feasibility of the mobile mindfulness-based stress reduction for breast cancer (mMBSR(BC)) program for symptom improvement among breast cancer survivors. Psychooncology 2018 Feb;27(2):524-531 [FREE Full text] [doi: 10.1002/pon.4491] [Medline: 28665541]</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main" xml:id="_644USkh">The effects of the combined exercise intervention based on internet and social media software (CEIBISMS) on quality of life, muscle strength and cardiorespiratory capacity in Chinese postoperative breast cancer patients:a randomized controlled trial</title>
		<author>
			<persName><forename type="first">X</forename><surname>Dong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Yi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chao</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12955-019-1183-0</idno>
		<idno>Medline: 31242926</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dvz5jTP">Health Qual Life Outcomes</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">109</biblScope>
			<date type="published" when="2019-06-26">2019 Jun 26</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Dong X, Yi X, Gao D, Gao Z, Huang S, Chao M, et al. The effects of the combined exercise intervention based on internet and social media software (CEIBISMS) on quality of life, muscle strength and cardiorespiratory capacity in Chinese postoperative breast cancer patients:a randomized controlled trial. Health Qual Life Outcomes 2019 Jun 26;17(1):109 [FREE Full text] [doi: 10.1186/s12955-019-1183-0] [Medline: 31242926]</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_GxfFpCs">PATI: patient accessed tailored information: a pilot study to evaluate the effect on preoperative breast cancer patients of information delivered via a mobile application</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Foley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Connell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Lehane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Livingstone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Maher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kaimkhani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.breast.2016.08.012</idno>
		<idno>Medline: 27611236</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Bk2tymJ">Breast</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="54" to="58" />
			<date type="published" when="2016-12">2016 Dec</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Foley NM, O&apos;Connell EP, Lehane EA, Livingstone V, Maher B, Kaimkhani S, et al. PATI: patient accessed tailored information: a pilot study to evaluate the effect on preoperative breast cancer patients of information delivered via a mobile application. Breast 2016 Dec;30:54-58 [doi: 10.1016/j.breast.2016.08.012] [Medline: 27611236]</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main" xml:id="_hGkwxkh">Depression screening using daily mental-health ratings from a smartphone application for breast cancer patients</title>
		<author>
			<persName><forename type="first">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Min</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">W</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Sohn</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.5598</idno>
		<idno>Medline: 27492880</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DdBc2Fa">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">e216</biblScope>
			<date type="published" when="2016-08-04">2016 Aug 04</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Kim J, Lim S, Min YH, Shin YW, Lee B, Sohn G, et al. Depression screening using daily mental-health ratings from a smartphone application for breast cancer patients. J Med Internet Res 2016 Aug 04;18(8):e216 [FREE Full text] [doi: 10.2196/jmir.5598] [Medline: 27492880]</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main" xml:id="_MGTRabF">Pilot implementation to assess the feasibility and care team impact of an app-based interactive care plan to remotely monitor breast cancer survivors</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Stan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Inselman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Ridgeway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">N</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Christopherson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Mccolley</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11764-021-01136-1</idno>
		<idno>Medline: 35107791</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Sf7JzCQ">J Cancer Surviv</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="13" to="23" />
			<date type="published" when="2022-03">2022 Mar</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Stan DL, Inselman JW, Ridgeway JL, Johnson KN, Christopherson LA, McColley SM, et al. Pilot implementation to assess the feasibility and care team impact of an app-based interactive care plan to remotely monitor breast cancer survivors. J Cancer Surviv 2022 Mar;16(1):13-23 [FREE Full text] [doi: 10.1007/s11764-021-01136-1] [Medline: 35107791]</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main" xml:id="_ah43uaw">A mobile breast cancer survivorship care app: pilot study</title>
		<author>
			<persName><forename type="first">J</forename><surname>Baseman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Revere</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Baldwin</surname></persName>
		</author>
		<idno type="DOI">10.2196/cancer.8192</idno>
		<idno>Medline: 28951383</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DTaYzQC">JMIR Cancer</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">2</biblScope>
			<date type="published" when="2017-09-26">2017 Sep 26</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Baseman J, Revere D, Baldwin LM. A mobile breast cancer survivorship care app: pilot study. JMIR Cancer 2017 Sep 26;3(2):e14 [FREE Full text] [doi: 10.2196/cancer.8192] [Medline: 28951383]</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main" xml:id="_zP7ZqMa">Effects of psychoeducational interventions using mobile apps and mobile-based online group discussions on anxiety and self-esteem in women with breast cancer: randomized controlled trial</title>
		<author>
			<persName><forename type="first">E</forename><surname>Ghanbari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yektatalab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mehrabi</surname></persName>
		</author>
		<idno type="DOI">10.2196/19262</idno>
		<idno>Medline: 34003138</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_M95gu6w">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">e19262</biblScope>
			<date type="published" when="2021-05-18">2021 May 18</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Ghanbari E, Yektatalab S, Mehrabi M. Effects of psychoeducational interventions using mobile apps and mobile-based online group discussions on anxiety and self-esteem in women with breast cancer: randomized controlled trial. JMIR Mhealth Uhealth 2021 May 18;9(5):e19262 [FREE Full text] [doi: 10.2196/19262] [Medline: 34003138]</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main" xml:id="_4KqwGFA">Reduced symptom burden with the support of an interactive app during neoadjuvant chemotherapy for breast cancer -a randomized controlled trial</title>
		<author>
			<persName><forename type="first">M</forename><surname>Fjell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Langius-Eklöf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nilsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wengström</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sundberg</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.breast.2020.03.004</idno>
		<idno>Medline: 32247251</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6xKA32a">Breast</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="85" to="93" />
			<date type="published" when="2020-06">2020 Jun</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Fjell M, Langius-Eklöf A, Nilsson M, Wengström Y, Sundberg K. Reduced symptom burden with the support of an interactive app during neoadjuvant chemotherapy for breast cancer -a randomized controlled trial. Breast 2020 Jun;51:85-93 [FREE Full text] [doi: 10.1016/j.breast.2020.03.004] [Medline: 32247251]</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main" xml:id="_mNXRggQ">Quality of life of women after a first diagnosis of breast cancer using a self-management support mHealth app in Taiwan: randomized controlled trial</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">C</forename><surname>Hou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Tai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Tsai</surname></persName>
		</author>
		<idno type="DOI">10.2196/17084</idno>
		<idno>Medline: 32130181</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_r9Wx7Zb">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">17084</biblScope>
			<date type="published" when="2020-03-04">2020 Mar 04</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Hou IC, Lin HY, Shen SH, Chang KJ, Tai HC, Tsai AJ, et al. Quality of life of women after a first diagnosis of breast cancer using a self-management support mHealth app in Taiwan: randomized controlled trial. JMIR Mhealth Uhealth 2020 Mar 04;8(3):e17084 [FREE Full text] [doi: 10.2196/17084] [Medline: 32130181]</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main" xml:id="_B65PMhP">Mobile app for symptom management and associated quality of life during systemic treatment in early stage breast cancer: nonrandomized controlled prospective cohort study</title>
		<author>
			<persName><forename type="first">Grašič</forename><surname>Kuhar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Gortnar</forename><surname>Cepeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kovač</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kukar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Ružić</forename><surname>Gorenjec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename></persName>
		</author>
		<idno type="DOI">10.2196/17408</idno>
		<idno>Medline: 32427567</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TN3YtZc">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">17408</biblScope>
			<date type="published" when="2020-08-04">2020 Aug 04</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Grašič Kuhar C, Gortnar Cepeda T, Kovač T, Kukar M, Ružić Gorenjec N. Mobile app for symptom management and associated quality of life during systemic treatment in early stage breast cancer: nonrandomized controlled prospective cohort study. JMIR Mhealth Uhealth 2020 Aug 04;8(8):e17408 [FREE Full text] [doi: 10.2196/17408] [Medline: 32427567]</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main" xml:id="_uB3N5xN">Mobile breast cancer e-support program for Chinese women with breast cancer undergoing chemotherapy (part 2): multicenter randomized controlled trial</title>
		<author>
			<persName><forename type="first">J</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ebert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Chan</surname></persName>
		</author>
		<idno type="DOI">10.2196/mhealth.9438</idno>
		<idno>Medline: 29712622</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2BzZ6h6">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">e104</biblScope>
			<date type="published" when="2018-04-30">2018 Apr 30</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Zhu J, Ebert L, Liu X, Wei D, Chan SW. Mobile breast cancer e-support program for Chinese women with breast cancer undergoing chemotherapy (part 2): multicenter randomized controlled trial. JMIR Mhealth Uhealth 2018 Apr 30;6(4):e104 [FREE Full text] [doi: 10.2196/mhealth.9438] [Medline: 29712622]</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main" xml:id="_srUANRz">A mobile game for patients with breast cancer for chemotherapy self-management and quality-of-life improvement: randomized controlled trial</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Jang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">I</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Han</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.9559</idno>
		<idno>Medline: 30578205</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WTs2DDH">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page">273</biblScope>
			<date type="published" when="2018-10-29">2018 Oct 29</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Kim HJ, Kim SM, Shin H, Jang JS, Kim YI, Han DH. A mobile game for patients with breast cancer for chemotherapy self-management and quality-of-life improvement: randomized controlled trial. J Med Internet Res 2018 Oct 29;20(10):e273 [FREE Full text] [doi: 10.2196/jmir.9559] [Medline: 30578205]</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main" xml:id="_QrP7sMv">Cardiorespiratory fitness in breast cancer survivors: a randomised controlled trial of home-based smartphone supported high intensity interval training</title>
		<author>
			<persName><forename type="first">E</forename><surname>Ochi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tsuji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Narisawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shimizu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kuchiba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Suto</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmjspcare-2021-003141</idno>
		<idno>Medline: 34389552</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gaFfKaW">BMJ Support Palliat Care</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="33" to="37" />
			<date type="published" when="2022-03">2022 Mar</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Ochi E, Tsuji K, Narisawa T, Shimizu Y, Kuchiba A, Suto A, et al. Cardiorespiratory fitness in breast cancer survivors: a randomised controlled trial of home-based smartphone supported high intensity interval training. BMJ Support Palliat Care 2022 Mar;12(1):33-37 [FREE Full text] [doi: 10.1136/bmjspcare-2021-003141] [Medline: 34389552]</note>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main" xml:id="_zFx2jhA">A web-and mobile-based intervention for women treated for breast cancer to manage chronic pain and symptoms related to lymphedema: results of a randomized clinical trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Axelrod</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Guth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Scagliola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rampertaap</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>El-Shammaa</surname></persName>
		</author>
		<idno type="DOI">10.2196/29485</idno>
		<idno>Medline: 35037883</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_F5EJDt9">JMIR Cancer</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">e29485</biblScope>
			<date type="published" when="2022-01-17">2022 Jan 17</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Fu MR, Axelrod D, Guth AA, Scagliola J, Rampertaap K, El-Shammaa N, et al. A web-and mobile-based intervention for women treated for breast cancer to manage chronic pain and symptoms related to lymphedema: results of a randomized clinical trial. JMIR Cancer 2022 Jan 17;8(1):e29485 [FREE Full text] [doi: 10.2196/29485] [Medline: 35037883]</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main" xml:id="_RR8EQne">Effect of mobile phone app-based training on the quality of life for women with breast cancer</title>
		<author>
			<persName><forename type="first">D</forename><surname>Çınar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Karadakovan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Erdoğan</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ejon.2021.101960</idno>
		<idno>Medline: 33882446</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4PPbnWK">Eur J Oncol Nurs</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page">101960</biblScope>
			<date type="published" when="2021-06">2021 Jun</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Çınar D, Karadakovan A, Erdoğan AP. Effect of mobile phone app-based training on the quality of life for women with breast cancer. Eur J Oncol Nurs 2021 Jun;52:101960 [doi: 10.1016/j.ejon.2021.101960] [Medline: 33882446]</note>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main" xml:id="_C4QaqbK">Mobile health and supervised rehabilitation versus mobile health alone in breast cancer survivors: randomized controlled trial</title>
		<author>
			<persName><forename type="first">M</forename><surname>Lozano-Lozano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Martín-Martín</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Galiano-Castillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fernández-Lao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cantarero-</forename><surname>Villanueva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename></persName>
		</author>
		<author>
			<persName><forename type="first">López-</forename><surname>Barajas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">B</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.rehab.2019.07.007</idno>
		<idno>Medline: 31454561</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9Q9VeZb">Ann Phys Rehabil Med</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="316" to="324" />
			<date type="published" when="2020-07">2020 Jul</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Lozano-Lozano M, Martín-Martín L, Galiano-Castillo N, Fernández-Lao C, Cantarero-Villanueva I, López-Barajas IB, et al. Mobile health and supervised rehabilitation versus mobile health alone in breast cancer survivors: randomized controlled trial. Ann Phys Rehabil Med 2020 Jul;63(4):316-324 [FREE Full text] [doi: 10.1016/j.rehab.2019.07.007] [Medline: 31454561]</note>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main" xml:id="_YNWKAS6">Brief culturally informed smartphone interventions decrease breast cancer symptom burden among Latina breast cancer survivors</title>
		<author>
			<persName><forename type="first">B</forename><surname>Yanez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Oswald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Baik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Buitrago</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Iacobelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Perez-Tamayo</surname></persName>
		</author>
		<idno type="DOI">10.1002/pon.5281</idno>
		<idno>Medline: 31693265</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_F8XWZzN">Psychooncology</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="195" to="203" />
			<date type="published" when="2020-01">2020 Jan</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Yanez B, Oswald LB, Baik SH, Buitrago D, Iacobelli F, Perez-Tamayo A, et al. Brief culturally informed smartphone interventions decrease breast cancer symptom burden among Latina breast cancer survivors. Psychooncology 2020 Jan;29(1):195-203 [FREE Full text] [doi: 10.1002/pon.5281] [Medline: 31693265]</note>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main" xml:id="_K6DYXzP">Feasibility of a mobile phone app and telephone coaching survivorship care planning program among Spanish-speaking breast cancer survivors</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Nápoles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Santoyo-Olsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Chacón</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Dixit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ortiz</surname></persName>
		</author>
		<idno type="DOI">10.2196/13543</idno>
		<idno>Medline: 31290395</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_a3FGjDK">JMIR Cancer</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">13543</biblScope>
			<date type="published" when="2019-07-09">2019 Jul 09</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Nápoles AM, Santoyo-Olsson J, Chacón L, Stewart AL, Dixit N, Ortiz C. Feasibility of a mobile phone app and telephone coaching survivorship care planning program among Spanish-speaking breast cancer survivors. JMIR Cancer 2019 Jul 09;5(2):e13543 [FREE Full text] [doi: 10.2196/13543] [Medline: 31290395]</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main" xml:id="_zhwHdpQ">Increasing adherence to adjuvant hormone therapy among patients with breast cancer: a smart phone app-based pilot study</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Krok-Schoen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Naughton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Moon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Poi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Melin</surname></persName>
		</author>
		<idno type="DOI">10.1177/1073274819883287</idno>
		<idno>Medline: 31736324</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xyzfzFe">Cancer Control</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">1073274819883287</biblScope>
			<date type="published" when="2019-01">2019 Jan</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Krok-Schoen JL, Naughton MJ, Young GS, Moon J, Poi M, Melin SA, et al. Increasing adherence to adjuvant hormone therapy among patients with breast cancer: a smart phone app-based pilot study. Cancer Control 2019 Jan;26(1):1073274819883287 [FREE Full text] [doi: 10.1177/1073274819883287] [Medline: 31736324]</note>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main" xml:id="_WAtj9Za">Smartphone problem-solving therapy to reduce fear of cancer recurrence among breast cancer survivors: an open single-arm pilot study</title>
		<author>
			<persName><forename type="first">F</forename><surname>Imai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Momino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Katsuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Horikoshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Furukawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kondo</surname></persName>
		</author>
		<idno type="DOI">10.1093/jjco/hyz005</idno>
		<idno>Medline: 30793156</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TNFvyGv">Jpn J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="537" to="544" />
			<date type="published" when="2019-06-01">2019 Jun 01</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Imai F, Momino K, Katsuki F, Horikoshi M, Furukawa TA, Kondo N, et al. Smartphone problem-solving therapy to reduce fear of cancer recurrence among breast cancer survivors: an open single-arm pilot study. Jpn J Clin Oncol 2019 Jun 01;49(6):537-544 [doi: 10.1093/jjco/hyz005] [Medline: 30793156]</note>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main" xml:id="_4Kta9Q4">Group medical consultations (GMCs) and tablet-based online support group sessions in the follow-up of breast cancer: a multicenter randomized controlled trial</title>
		<author>
			<persName><forename type="first">A</forename><surname>Visser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Prins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Jansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Radema</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Schlooz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Van Dalen</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.breast.2018.05.012</idno>
		<idno>Medline: 29906741</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_upsWs3G">Breast</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="181" to="188" />
			<date type="published" when="2018-08">2018 Aug</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Visser A, Prins JB, Jansen L, Radema SA, Schlooz MS, van Dalen T, et al. Group medical consultations (GMCs) and tablet-based online support group sessions in the follow-up of breast cancer: a multicenter randomized controlled trial. Breast 2018 Aug;40:181-188 [doi: 10.1016/j.breast.2018.05.012] [Medline: 29906741]</note>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main" xml:id="_PHytk9c">Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trial</title>
		<author>
			<persName><forename type="first">I</forename><surname>Graetz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Mckillop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Stepanski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Vidal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Schwartzberg</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11764-018-0682-z</idno>
		<idno>Medline: 29492753</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Nekhjqj">J Cancer Surviv</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="431" to="440" />
			<date type="published" when="2018-08">2018 Aug</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Graetz I, McKillop CN, Stepanski E, Vidal GA, Anderson JN, Schwartzberg LS. Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trial. J Cancer Surviv 2018 Aug;12(4):431-440 [FREE Full text] [doi: 10.1007/s11764-018-0682-z] [Medline: 29492753]</note>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main" xml:id="_s5qzhQ2">Effects of exercise intervention in breast cancer patients: is mobile health (mHealth) with pedometer more effective than conventional program using brochure?</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Uhm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Yoo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Kim</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10549-016-4065-8</idno>
		<idno>Medline: 27933450</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jzfxd4D">Breast Cancer Res Treat</title>
		<imprint>
			<biblScope unit="volume">161</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="443" to="452" />
			<date type="published" when="2017-03">2017 Mar</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Uhm KE, Yoo JS, Chung SH, Lee JD, Lee I, Kim JI, et al. Effects of exercise intervention in breast cancer patients: is mobile health (mHealth) with pedometer more effective than conventional program using brochure? Breast Cancer Res Treat 2017 Mar;161(3):443-452 [doi: 10.1007/s10549-016-4065-8] [Medline: 27933450]</note>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main" xml:id="_YdhZm4j">Can psychomotricity improve cognitive abilities in infants?</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Mas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Castellà</surname></persName>
		</author>
		<idno type="DOI">10.51698/aloma.2016.34.1.65-70</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pTPPk9n">Rev Psicol Ciènc Educ Esport Blanquerna</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="65" to="70" />
			<date type="published" when="2016-05-18">2016 May 18</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Mas MT, Castellà J. Can psychomotricity improve cognitive abilities in infants? Rev Psicol Ciènc Educ Esport Blanquerna 2016 May 18;34(1):65-70 [FREE Full text] [doi: 10.51698/aloma.2016.34.1.65-70]</note>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main" xml:id="_TjHb5xX">Effect of psychomotricity in combination with 3 months of active shoulder exercises in individuals with chronic shoulder pain: primary results from an investigator-blinded, randomized, controlled trial</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Ingwersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Vobbe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Pedersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sørensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Wedderkopp</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.apmr.2019.05.032</idno>
		<idno>Medline: 31247165</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_drwE8FD">Arch Phys Med Rehabil</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="2136" to="2143" />
			<date type="published" when="2019-11">2019 Nov</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Ingwersen KG, Vobbe JW, Pedersen LL, Sørensen L, Wedderkopp N. Effect of psychomotricity in combination with 3 months of active shoulder exercises in individuals with chronic shoulder pain: primary results from an investigator-blinded, randomized, controlled trial. Arch Phys Med Rehabil 2019 Nov;100(11):2136-2143 [FREE Full text] [doi: 10.1016/j.apmr.2019.05.032] [Medline: 31247165]</note>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main" xml:id="_Qmh7qrR">Breast cancer survivors&apos; preferences for mHealth physical activity interventions: findings from a mixed methods study</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Phillips</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Courneya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Welch</forename><forename type="middle">Wa</forename><surname>Gavin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Cottrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nielsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<idno type="DOI">10.1007/s11764-019-00751-3</idno>
		<idno>Medline: 30912011</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3F58Udp">J Cancer Surviv</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="292" to="305" />
			<date type="published" when="2019-04">2019 Apr</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Phillips SM, Courneya KS, Welch WA, Gavin KL, Cottrell A, Nielsen A, et al. Breast cancer survivors&apos; preferences for mHealth physical activity interventions: findings from a mixed methods study. J Cancer Surviv 2019 Apr;13(2):292-305 [FREE Full text] [doi: 10.1007/s11764-019-00751-3] [Medline: 30912011]</note>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main" xml:id="_66awdnp">Mobile health applications for the care of patients with breast cancer: a scoping review</title>
		<author>
			<persName><forename type="first">T</forename><surname>Cai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Yuan</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijnss.2021.07.003</idno>
		<idno>Medline: 34631997</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_NCWQ78H">Int J Nurs Sci</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="470" to="476" />
			<date type="published" when="2021-10-10">2021 Oct 10</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Cai T, Huang Y, Zhang Y, Lu Z, Huang Q, Yuan C. Mobile health applications for the care of patients with breast cancer: a scoping review. Int J Nurs Sci 2021 Oct 10;8(4):470-476 [FREE Full text] [doi: 10.1016/j.ijnss.2021.07.003] [Medline: 34631997]</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
